cefoperazone has been researched along with sulbactam in 340 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 71 (20.88) | 18.7374 |
1990's | 97 (28.53) | 18.2507 |
2000's | 52 (15.29) | 29.6817 |
2010's | 76 (22.35) | 24.3611 |
2020's | 44 (12.94) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH | 1 |
Aoki, I; Kikuchi, M; Torii, Y; Toyama, K; Wakasugi, K | 1 |
Hara, K; Higashiyama, Y; Koga, H; Kohno, S; Maesaki, S; Matsuda, H; Mitsutake, K; Miyazaki, Y; Yamada, H; Yoshitomi, Y | 1 |
Barry, AL; Fuchs, PC; Gerlach, EH; Hardy, DJ; McLaughlin, JC; Pfaller, MA | 1 |
Livermore, DM | 1 |
Bawdon, RE; Castle, S; Norman, DC; Rho, JP; Smith, K | 1 |
Bradford, PA; Sanders, CC | 1 |
Arai, K; Miyajima, H; Sakai, N; Shimizu, T | 1 |
Bartelt, MA; Chan, EL; Clark, RB; Dalton, HP | 1 |
Horiba, M; Suzuki, K | 2 |
Atabey, N; Gökoğlu, M | 1 |
Ayers, OM; Everett, BQ; Hill, GB | 1 |
Hara, H; Kakishita, E; Kanamaru, A; Mitsutani, S; Nakayama, S; Sonoda, T; Tago, H; Takemoto, Y; Tsutsui, T; Yamaguchi, N | 1 |
Iida-Tanaka, K; Irino, S; Tanaka, T | 1 |
Acar, JF; Denis, F; Drugeon, H; Fleurette, J; Kazmierczak, A; Siebor, E; Sirot, J; Soussy, CJ; Thabaut, A | 1 |
Cavalieri, SJ; New, C; Sanders, CC | 1 |
Kimura, I; Kitamura, K; Masaoka, T; Miyazaki, T; Mizoguchi, H; Niho, Y; Saito, H; Takaku, F | 1 |
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR; Sinn, LM | 2 |
Anderson, PH; Barry, AL; Fuchs, PC; Shilling, S; Stickel, S | 1 |
Kobayashi, J; Kouda, M; Kumagai, I; Matsuzaki, H; Sugai, R | 2 |
D'Amato, RF; Fass, RJ; Gregory, WW; Matsen, JM; Wright, DN; Young, LS | 1 |
Appelbaum, PC; Fabian, TC; Hageage, G; Jauregui, LE; Martin, LF; Strausbaugh, L | 1 |
Hara, N; Ichikawa, Y; Ishibashi, T; Kido, M; Kitahara, Y; Ninomiya, K; Shinoda, A; Takamoto, M; Tsurutani, H; Yoshida, M | 1 |
Ayame, H; Fujii, Y; Fujita, N; Hatao, K; Inoue, H; Kaku, K; Kaneko, T; Miyoshi, K; Murano, K; Yaga, K | 1 |
Deguchi, K; Fukayama, S; Fukushima, Y; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Sato, K; Tanaka, S; Yokota, N | 1 |
Barry, AL; Jones, RN | 2 |
Baykal, M; Hasçelik, G | 1 |
Sanders, CC; Sanders, WE; Thomson, KS; Weber, DA | 1 |
Földes, J; Hajdu, E; Nagy, E | 1 |
Eliopoulos, GM; Ferraro, MJ; Klimm, K; Moellering, RC | 1 |
Hashimoto, H; Morikawa, M; Nishimoto, M; Okamura, K; Osani, H; Saga, Y; Yachiku, S; Yamauchi, K | 1 |
Alicea, M; Colucci, RD; Greenstein, R; Halpern, NA | 1 |
Matsuo, K; Uete, T | 2 |
Akutsu, I; Fukuda, T; Ikemori, R; Makino, S; Motojima, S; Ogata, H; Otsuka, T; Sagara, H | 1 |
Bawdon, RE; Bernstein, SG; Heard, MC; Hemsell, DL; Hemsell, PG; Nobles, BJ | 1 |
Hamaguchi, M; Hotta, T; Inoue, C; Morishita, T; Murate, T; Ogura, M; Ohnishi, K; Ohno, R; Okumura, M; Tanimoto, M | 1 |
Hirayama, H; Kashiwagura, T; Matsuda, S | 1 |
Haginaka, J; Nakagawa, T; Uno, T; Wakai, J; Yasuda, H | 1 |
Ando, M; Horisawa, M; Iriyama, K; Ishikawa, S; Kataoka, M; Kondo, T; Masaoka, A; Shinagawa, N; Suzuki, H; Yura, J | 1 |
Barry, AL; Jones, RN; Thornsberry, C; Wilson, HW | 2 |
Barry, AL; Jones, RN; Packer, RR | 2 |
Bawdon, RE; Madsen, PO | 1 |
Jacobus, NV; Souza Dias, MB; Tally, FP | 1 |
Ito, T; Tamura, M | 1 |
Araki, T; Chigusa, I; Hayashi, N; Kawahara, S; Kawamura, J; Okabe, S; Saito, K; Suzuki, I; Suzuki, N; Takeno, K | 1 |
Baum, M; Bawdon, RE; Fortunato, SJ | 1 |
Aoyama, H; Izawa, Y; Okuda, J; Sugiyama, H; Tada, M | 1 |
Bollinger, M; Greenberg, RN; Kennedy, DJ; Reilly, PM; Weinandt, WJ | 1 |
Arnold, J; Blickens, D; Chung, M; Reitberg, DP; Swarz, H; Whall, TJ | 1 |
Craig, WA; Johnson, CA; Leggett, JE; Reitberg, DP; Whall, TJ; Zimmerman, SW | 1 |
Finegold, SM; Wexler, HM | 1 |
Marble, DA; Reitberg, DP; Schentag, JJ; Schultz, RW; Whall, TJ | 1 |
Bachmann, KA; Jauregui, LE; Martin, ME; Reitberg, DP; Schwartz, JI | 1 |
Deguchi, K; Fukayama, S; Kato, M; Koguchi, M; Nakane, Y; Nishimura, Y; Oda, S; Sato, K; Tanaka, S; Yokota, N | 1 |
Barry, AL; Gregory, WW; Jones, RN; Packer, RR; Thornsberry, C | 1 |
Barry, AL; Fuchs, PC; Jones, RN | 1 |
Aoyama, R; Asuka, N; Izumi, Y; Ohnishi, A; Waga, S | 1 |
Honjo, T; Watanabe, A | 1 |
Himi, K; Kurosaki, T; Matsumura, C; Nakamura, A; Sugaya, N; Suzuki, H; Terashima, I; Uehara, S | 1 |
Hachimori, K; Kaneda, K; Minamitani, M | 1 |
Hirosawa, H; Hoshina, H; Ichihashi, H; Mikuni, K | 1 |
Arimasu, O; Fujii, R; Mashiko, J; Meguro, H; Nonaka, C; Tajima, T | 1 |
Akita, H; Hayano, S; Iwasaki, Y; Iwata, S; Kojima, Y; Oikawa, T; Osano, M; Sato, Y; Sunakawa, K; Wakabayashi, R | 1 |
Hakamada, S; Hayakawa, F; Kuno, K; Miyachi, Y; Nakashima, T; Ueda, S | 1 |
Iwai, N; Katayama, M; Mizoguchi, F; Shibata, M; Taneda, Y | 1 |
Nishimura, T; Tabuki, K; Takagi, M; Takashima, T | 1 |
Haruta, T; Kobayashi, Y; Kuroki, S; Ohkura, K | 1 |
Fujimoto, T; Ishimoto, K; Koga, T; Motohiro, T; Nishiyama, T; Sakata, Y; Shimada, Y; Tanaka, K; Tominaga, K; Tomita, N | 1 |
Maki, M; Saito, Y; Tachizaki, T | 1 |
Domon, H; Eto, M; Kodama, M; Sato, H; Shimizu, T; Washizuka, N | 1 |
Chimura, T; Inoue, K; Morisaki, N | 1 |
Hirai, S; Iida, S; Kohara, T; Matsui, Y; Noda, M | 1 |
Cho, N; Fukunaga, K; Kunii, K; Moriyama, S; Takeda, H; Tsukamoto, A; Watanabe, H; Yoshida, K | 1 |
Hayashi, S; Iwata, Y; Nakamura, H | 1 |
Shitano, T; Tateno, M | 1 |
Asamoto, A; Hoshiba, T; Yabuki, Y | 1 |
Fukuda, O; Inoue, S; Maeyama, M; Shimokawa, K | 1 |
Chikaoka, H; Nakazawa, S; Narita, A; Sato, H; Suzuki, H; Tazoe, K | 1 |
Arai, K; Hogaki, M; Ikegawa, A; Seto, H | 1 |
Hayasaki, M; Ito, K; Kondo, H; Noda, K | 1 |
Ichijo, M; Kosakai, H; Moriyama, I; Shintani, M; Takayama, T | 1 |
Horii, T; Noda, K | 1 |
Kanao, M; Okada, H; Yamamoto, T; Yasuda, J | 1 |
Hirabayashi, K; Okada, E | 1 |
Kubota, K | 1 |
Doko, F | 1 |
Ikushima, Y; Kobayashi, H; Matsumoto, S; Shirakawa, K | 1 |
Arimasu, O; Fujii, R; Honjo, T; Mashiko, J; Meguro, H; Nagamatsu, I; Nonaka, C; Sato, Y; Tajima, T; Watanabe, A | 1 |
Hori, M; Kurosu, Y; Nakamura, H; Sugita, M; Takahashi, T; Toyonaga, Y | 1 |
Hachiya, S; Imagawa, N; Koike, K; Morimoto, O; Obata, I; Ochiai, K; Ryu, F | 1 |
Fu, KP; Neu, HC | 1 |
Washington, JA; Yu, PK | 1 |
Crosby, MA; Gump, DW | 1 |
Foulds, G; Hayes, SL; Marshall, DC; McMahon, FG; O'Brien, MM; Stankewich, JP; Weidler, DJ | 1 |
Baumgärtner, M | 1 |
Ariyama, Y; Hirakawa, K; Horiike, S; Kaneko, H; Kashima, K; Misawa, S; Nakao, M; Taniwaki, M; Tsuda, S; Ueda, Y | 1 |
Harashima, S; Okada, K; Sawae, Y; Takaki, K; Takeda, T; Tanaka, M; Umeno, M | 1 |
Okuyama, S | 1 |
Ishibashi, C; Mishina, H; Okuyama, S; Sato, A | 1 |
Ansolis, LE; Budanov, SV; Kuleshov, SE; Navashin, SM; Rezvan, SP; Sidorenko, SV; Speranskaia, ON; Tikhonova, As; Tsvigun, EA | 1 |
Iakovlev, VP | 1 |
Budanov, SV; Rezvan, SP; Sidorenko, SV | 1 |
Blatun, LA; Iakovlev, VP; Puchkova, LS; Svetukhin, AM | 1 |
Eber, B; Gasser, RN; Klein, W; Pokan, R; Reisinger, EC; Seinost, G; Wendelin, I | 1 |
Bowen, K; Cayavec, P; Danko, LS; Greenberg, RN; Johnson, SB; Kearney, PA; Montazemi, R; Strodel, WE | 1 |
Fasching, CE; Fasola, EL; Peterson, LR | 1 |
Danziger, LH; Occhipinti, DJ; Piscitelli, SC; Resnick, DJ; Rodvold, KA | 1 |
Hayashi, I; Ichiki, M; Ishikawa, T; Karato, A; Niida, M; Ogawa, M; Sakurai, M; Sekine, I; Shiotani, J; Yoshida, T | 1 |
Garcia-Villanova, J; Gomez, MD; Parra, A; Rodenas, V | 1 |
Iwasaki, H; Kawai, Y; Nakamura, T; Ueda, T | 1 |
Deguchi, K; Hashimoto, H; Kohmoto, A; Niida, M; Ogawa, M; Yoshida, T | 1 |
Hayashi, I; Ichiki, M; Koumoto, A; Nakayama, K; Niida, M; Ogawa, M; Sakurai, M; Sekine, I; Shiotani, J; Yoshida, T | 1 |
Baker, M; Chang, Y; Danko, LS; Greenberg, RN; Meade, DW | 1 |
Deguchi, K; Fukayama, S; Fukumoto, T; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Tanaka, S; Yokota, N | 1 |
Hirose, S; Inoue, T; Ito, K; Mano, K; Mita, S; Morita, Y; Sukoh, M; Takahashi, T; Togano, Y; Yamanaka, K | 1 |
Benjamin, R; Bodey, GP; Elting, LS; Estey, E; Koller, C; Narro, J; O'Brien, S | 1 |
Kawada, E; Maehara, T; Matsushima, T; Morita, K; Murayama, K; Okamoto, K; Sadakata, H; Sawamura, M; Tamura, J; Tamura, K | 1 |
Chandrasekar, PH; Kruse, JA; Sluchak, JA | 1 |
Fukuda, M; Hirashima, K | 1 |
Akutsu, I; Arima, M; Asakawa, J; Ezure, M; Fukuda, T; Hirata, S; Motojima, S; Nakajima, H; Sagara, H; Tateishi, K | 1 |
Chambers, HF; Fournier, MA | 1 |
Hara, H; Inoue, N; Kakishita, E; Kanamaru, A; Murakami, R; Nakayama, S; Tago, H; Takemoto, Y; Tsutsui, T; Yamaguchi, N | 1 |
Aksoy, AM; Ekmen, H; Ozsan, M; Ural, O | 1 |
Carias, LL; Etter, L; Rice, LB; Shlaes, DM | 1 |
Hirakawa, K; Horiike, S; Kuzuyama, Y; Misawa, S; Nakai, H; Nishida, K; Seriu, T; Takashima, T; Tanaka, S; Tsuda, S | 1 |
Kuzuhara, S; Machii, K; Mezaki, T; Ohira, T; Watanabe, Y | 1 |
Alekseev, AA; Grishina, IA; Iakovlev, VP; Izotova, GN; Kashin, IuD; Krutikov, MG | 1 |
Chen, X; Xu, W | 1 |
Zhang, J; Zhang, Y; Zhou, L | 1 |
Hu, W; Li, J; Miao, J | 1 |
Kato, H; Kato, N; Tanaka, Y; Tanaka-Bandoh, K; Ueno, K; Watanabe, K | 1 |
Oono, Y; Sawa, T; Toyoda, M; Yokoyama, H; Yoshida, T | 1 |
Arakawa, Y; Ito, H; Kato, N; Kimura, K; Kurokawa, H; Ohsuka, S; Ohta, M; Suzuki, K | 1 |
Abi-Said, D; Bodey, G; Raad, I; Rolston, K; Whimbey, E | 1 |
Oyabu, Y | 1 |
Cheong, YM; Lim, VK | 1 |
Citron, DM; Goldstein, EJ | 1 |
Hara-Kudo, Y; Kasuga, F; Kumagai, S; Morishita, Y; Nagaoka, Y | 1 |
Abe, K; Dotsu, Y; Hara, K; Hashimoto, A; Hirakata, Y; Hori, H; Imamura, Y; Inoue, Y; Ishiguro, M; Kanda, T; Katsumata, T; Kawamoto, S; Koga, H; Kohno, S; Kusano, S; Mashimoto, H; Matsumoto, Y; Morikawa, N; Sasayama, K; Shimoguchi, K; Sugiyama, H; Tanaka, H; Tanaka, K; Tomono, K | 1 |
Williams, JD | 1 |
Chen, DK; Chen, YF; Gu, JM; Hou, J; Hu, WZ; Jia, YX; Li, JT; Li, LJ; Liu, DM; Lu, Y; Miao, JZ; Sun, L; Wang, HL; Wang, Z; Wu, J; Zhang, XZ; Zhang, YL | 1 |
Berglöff, J; Eber, B; Gasser, R; Horwarth, R; Klein, W; Pokan, R; Reisinger, E; Sedaj, B; Seinost, G | 1 |
Hanaki, H; Nagayama, A; Nomura, S | 1 |
Cheong, YM; Chiu, C; Chow, C; Kumarasinghe, G | 1 |
Doern, GV; Jones, RN; Pfaller, MA; Salazar, JC | 1 |
Bartoni, K; Bruckner, DA; Schiller, GJ; Territo, MC; Winston, DJ | 1 |
Tian, Y; Xu, Y; Zheng, X | 1 |
Hu, W; Li, J; Zhu, Y | 1 |
Chetchotisakd, P; Thamprajamchit, S; Thinkhamrop, B | 1 |
Amako, Y; Fujisaki, M; Hirano, M; Ishii, J; Itakura, M; Iwasa, T; Kako, M; Koyama, M; Mitamura, K; Nakaya, S; Nishio, T; Ohswawa, N; Ohyama, R; Okuda, K; Oohira, S; Saito, H; Shinagawa, N; Sugiyama, A; Takashima, S; Takeda, S; Ueda, M; Yamada, M; Yasuda, Y; Zeze, F | 1 |
Filatov, LB; Iarikova, EN; Isaev, VG; Kaletin, GI; Kaporskaia, TS; Kliasova, GA; Klimko, NN; Lapin, VA; Medvedeva, NV; Parovichnikova, EN; Porokhona, ON; Pristupa, AS; Rekhtman, GB; Rossiev, VA; Savchenko, VG; Sharov, LN; Tolkacheva, TV; Tumakov, VA | 1 |
Ann, E; Bessho, M; Dan, K; Egashira, M; Fukuda, M; Hirai, H; Hirasawa, A; Hirashima, K; Hoshino, T; Hosoya, N; Ikeda, Y; Karasawa, M; Kawai, N; Kitamura, K; Kizaki, M; Miura, Y; Miyazawa, K; Nagasu, M; Naruse, T; Noguchi, M; Ohmine, K; Oshimi, K; Sugai, M; Takagi, S; Toyama, K | 1 |
Fukuhara, J; Furuhata, N; Ikeda, A; Kimura, F; Kouda, M; Maruyama, M; Matsuzaki, H; Nomura, H; Ohgawara, M; Ono, E; Sasaki, K; Satoh, H; Sawabe, E; Suzuki, T; Takahashi, I; Takeuchi, M; Tohi, H | 1 |
Borja, J; Herreras, A | 1 |
Qin, W; Shi, Y; Wang, X | 1 |
Gürsel, I; Hasirci, V; Korkusuz, F; Korkusuz, P; Ors, U; Yagmurlu, MF | 1 |
Başkan, S; Ozyilkan, O; Yalçintaş, U | 1 |
Bao, D; Fan, X; Liu, B; Zhou, L | 1 |
Grosmanová, T; Klementa, I; Kolár, M; Král, V | 1 |
Cheong, YM; Koay, AS; Rohani, MY | 1 |
Alaeddinoglu, NG; Gürsel, I; Hasirci, V; Korkusuz, F; Türesin, F | 1 |
Nakae, T; Nakajima, A; Saito, K | 1 |
Bessho, M; Endo, K; Fukuda, M; Hirasima, K; Ito, K; Kawai, N; Tominaga, K | 1 |
Chikamitsu, M; Endoh, S; Fujita, Y; Kimura, M; Sari, A; Toriumi, T | 1 |
Anunnatsiri, S; Chetchotisakd, P; Mootsikapun, P; Porramatikul, S; Thinkhamrop, B | 1 |
Gürsel, I; Hasirci, V; Türesin, F | 1 |
Acar, O; Eser, O; Köroğlu, A; Tiraş, B; Ustün, ME | 1 |
Halijah, MY; Lim, VK | 1 |
Apisarnthanarak, A; Little, JR | 1 |
Büyükokuroğlu, ME; Ciftçi, M; Küfrevioğlu, OI | 1 |
Levin, AS | 1 |
Agarwala, S; Gayowski, T; Mirani, A; Muder, RR; Venkataramanan, R | 1 |
Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 1 |
Li, FS; Liang, XM; Xiao, HB; Xu, ZX | 1 |
Chen, MJ; Wang, H | 1 |
Mitrokhin, SD | 1 |
Beketov, AS; Komarov, RM; Pisarev, VV; Sidorenko, SV | 1 |
Li, L; Ma, Y; Yu, Y; Zhou, Z | 1 |
Demei, Z; Fu, W; Fupin, H; Shi, W; Yingyuan, Z | 1 |
Kawai, M; Kinoshita, H; Onishi, H; Tani, M; Uchiyama, K; Ueno, M; Yamaue, H | 1 |
Abe, T; Sato, Y; Sei, M | 1 |
Perederko, LV; Polikarpova, SV; Postnikov, SS; Semykin, SIu | 1 |
Lee, WS; Lin, ML; Liu, CY; Wang, FD | 1 |
Mukonin, AA; Ovsiankin, AV | 1 |
Dong, JH; Li, NF; Man, GT; Wu, WZ; Zeng, Z; Zhang, TL; Zhang, YD; Zhou, XS; Zou, SQ | 1 |
Chen, Y; Xu, J; Zhang, Q; Zheng, P | 1 |
Huang, JJ; Yu, JL; Zeng, Q | 1 |
Madsen, PO; Nielsen, KT | 1 |
Bachinskaia, EN; Beloborodova, NV; Kuznetsova, ST; Popov, DA; Vostrikov, TIu | 1 |
Das, BK; Dhawan, B; Kapil, A; Mohanty, S; Singhal, R; Sood, S | 1 |
Apisarnthanarak, A; Khawcharoenporn, T; Kiratisin, P; Mundy, LM | 1 |
Choi, JY; Kim, CO; Kim, JM; Kim, MS; Kim, YA; Kim, YK; Lee, K; Park, YS; Shin, SY; Song, YG; Yong, D; Yoon, HJ | 1 |
Hashikita, G; Kawakami, S; Kobayashi, S; Maesaki, S; Nagasawa, M; Okabe, T; Sasaki, K; Shibuya, S; Suzuki, N; Takayama, S; Uchida, T; Watanabe, M; Yamaguchi, T | 1 |
Basu, S; Mitra, S | 1 |
Chang, HT; Chen, IS; Chou, MY; Hsueh, PR; Huang, WK; Hung, MN; Ko, WC; Lee, WS; Lin, CF; Liu, CY; Liu, YC; Luh, KT; Shyr, JM; Teng, LJ; Wang, JH; Wu, JJ | 1 |
Apisarnthanarak, A; Mundy, LM | 1 |
Menon, T; Nandhakumar, B; Ravishankar, G; Shanmugasundaram, S | 1 |
Chen, SH; Huang, YC; Lee, AR; Lee, CW; Tsou, TL; Wang, HJ | 1 |
Abe, Y; Akimoto, K; Akiyama, T; Fujita, K; Goto, A; Inamori, M; Kirikoshi, H; Kubota, K; Kusakabe, A; Nakajima, A; Rino, Y; Sakai, H; Sato, T; Takahashi, H; Ueno, N; Yoneda, M | 1 |
Duan, X; Ling, F; Ren, SH; Yu, Z; Zhou, L; Zhou, TM | 1 |
Cherkashin, EA; Galeeva, EV; Ivanov, DV; Krapivina, IV; Sidorenko, SV; Veshutova, NS | 1 |
Akova, M | 1 |
Inoue, H; Iwata, Y; Kanamori, T; Kishi, T; Kuwayama, K; Miyaguchi, H; Tsujikawa, K | 1 |
Duttagupta, S; Kochhar, P; Sarkar, S; Suvarna, V | 1 |
Chandra, A; Desai, C; Dhar, P; Dharap, S; Goel, A; Gupta, R; Hardikar, JV; Kapoor, VK; Kochhar, P; Mathur, AK; Modi, P; Narwaria, M; Ramesh, H; Ramesh, MK; Sastry, RA; Schou, M; Shah, S; Somasundaram, S; Sreevathsa, MR; Sudheer, OV; Varshney, S; Virk, S | 1 |
Jezewska, G; Kostyra, K; Młynarczyk, A; Młynarczyk, G; Pastuszak, A; Sańczyk, E; Scibisz, A; Serafin, I; Sliwa, R; Winek, K; Wolska, M; Wysocka, PC; Łuczak, M | 1 |
Krishnan, S; Nagappa, AN; Rao, JV; Sivagurunathan, N; Subrahmanyam, VM; Vanathi, BM | 1 |
Duangrat, C; Kaewvichit, S; Niwatananun, W; Salee, P; Taesotikul, W; Thongsawat, S; Wongsinsup, C; Yotsawimonwat, S | 1 |
Chin, K; Fujimura, M; Ichikawa, T; Kajimoto, S; Kamijima, S; Mikami, K; Sekita, N; Suzuki, H | 1 |
Kuo, HY; Lin, ML; Liu, CY; Wang, FD; Yen, YF | 1 |
Mahadevan, S; Mandal, J; Mondal, N; Parija, SC | 1 |
Baek, EJ; Choi, HK; Kim, HO; Kim, S; Lee, S | 1 |
Guo, B; Shi, Y; Wang, M; Yu, J; Zhang, J; Zhang, Y; Zhou, Y | 1 |
Bethel, CR; Bonomo, RA; Drawz, SM; Ke, W; Ori, C; Prati, F; Sampson, JM; van den Akker, F | 1 |
Akachi, S; Kondo, M; Kurokawa, I; Nishii, M; Yamanaka, K | 1 |
Akyüz, C; Büyükpamukçu, M; Cengiz, B; Ceyhan, M; Demir, HA; Kara, A; Kutluk, T; Seçmeer, G; Varan, A; Yağcı-Küpeli, B; Yalçın, B | 1 |
Herych, ID; Vashchuk, VV | 1 |
Aoki, A; Iga, N; Inaba, T; Kawai, K; Miyahara, K; Suezawa, T; Tago, M; Wato, M | 1 |
Emecen, M; Erdem, E; Karaman, S; Kebudi, R; Vural, S; Yildirmak, Y | 1 |
Blahut, L; Hricová, K; Kolár, M; Neiser, J; Urbánek, K; Uvízl, R; Vojtová, V | 1 |
Fukushima, M; Ichijo, T; Ichikawa, Y; Joshita, S; Kamijo, A; Kimura, T; Matsumoto, A; Morita, S; Nozawa, Y; Sugiyama, Y; Tanaka, E; Umemura, T; Yoshizawa, K | 1 |
Aktas, A; Divrikli, D; Gursoy, T; Ovali, F; Sari, I | 1 |
Anjum, R; Fahim, Q; Gill, MM; Hassan, A; Kaleem, F; Khalid, A; Usman, J | 1 |
Tuğrul, HM; Yıldırım, MI | 1 |
Chitnis, DS; Chitnis, S; Hemvani, N; Katara, G | 1 |
Afridi, FI; Farooqi, BJ | 1 |
Altın, N; Argun, C; Canbakan, B; Cesur, S; Koldaş, K; Kurşun, O; Sencan, I; Unal, N | 1 |
Boĭko, VV; Ivanova, IuV | 1 |
Jurczak, A; Kaczyńska, K; Milewski, R; Ojdana, D; Sacha, P; Tryniszewska, E; Wieczorek, P | 1 |
Mao, Y; Pei, G; Sun, Y | 1 |
Bardale, RV; Deshmukh, AY; Dixit, PG; Tumram, NK | 1 |
Du, W; Liu, Y; Rui, X; Shi, Y; Wang, Y; Xu, YC | 1 |
Celebi, S; Demirkaya, M; Hacımustafaoglu, M; Sevinir, B | 1 |
Gao, ZH; Li, SM; Shen, JH; Zhang, BY | 1 |
Chen, Y; Du, X; Fu, Y; Ji, J; Wang, H; Yu, Y | 1 |
Cai, Z; Chen, P; Li, Y; Ma, G; Wang, L; Xu, R; Zhu, Z | 1 |
Amatya, R; Baral, R; Bhattacharya, SK; Bhattarai, NR; Gurung, R; Gyawali, N; Khanal, B; Poudyal, N; Shrestha, S | 1 |
Pesotskiĭ, ON | 1 |
Chhibba, A; Nayak, U; Patankar, M; Sequeira, L; Sukumaran, S | 1 |
Bao, Y; Cai, Y; Chai, T; Gao, J; Li, X; Ma, R; Zhao, X; Zhou, Y | 1 |
Boral, OB; Cağatay, P; Keçeli, SA; Sonmez, N; Tamer, GS; Willke, A | 1 |
Bosnak, VK; Karaoglan, I; Mete, AO; Namiduru, M; Zer, Y | 1 |
Qu, J; Wu, C; Zhang, L; Zhu, Z | 1 |
Huang, W; Huang, Y; Jia, B; Jian, L; Li, C; Sun, X; Tang, X; Wang, C; Xia, X; Xin, X; Zhang, W; Zhou, L; Zhu, Y | 1 |
Arda, B; Nazli-Zeka, A; Ozkoren-Calik, S; Pullukcu, H; Sipahi, H; Sipahi, OR; Tasbakan, M; Ulusoy, S; Yamazhan, T | 1 |
Hoang, VD; Loan, NT; Nguyen, HM; Tho, VT | 1 |
Chen, X; Du, W; Ning, F; Rong, Y; Shen, Y; Wang, C; Wen, C; Zhang, G; Zhao, X | 1 |
Fang, X; Gong, M; Xia, J; Xu, Y; Zhang, D; Zhou, Y | 1 |
Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Nikitina, OV; Reĭ, SI | 1 |
Jang, IH; Kim, HJ; Kim, J; Oh, JR; Park, SD; Uh, Y; Yoon, KJ | 1 |
Li, HX; Li, TZ; Wang, LW; Zou, L | 1 |
Arslan, U; Kus, H; Tuncer, I; Turk Dagi, H | 1 |
Makihata, E; Nagai, A; Okazaki, J; Ono, K; Takeda, M | 1 |
Babarina, MB; Sanadze, AG; Sokolova, VI; Sychev, DA; Zaĭkov, DA | 1 |
Bai, Y; Di, X; Liu, B; Liu, Y; Wang, J; Wang, R; Zhang, X | 1 |
Lai, J; Li, S; Liang, L; Peng, B; Wang, Z; Zheng, J | 1 |
Chen, B; Wang, Q; Wu, Y; Zhou, J | 1 |
Araya, I; Contreras, S; Fasce, G; Hurtado, V; Núñez, E; Opazo, JL; Quiñones, LA; Saez, E | 1 |
Chen, J; Feng, Y; Xu, Q; Zhan, R | 1 |
Dong, Y; Wang, T; Wang, Y; Xie, J; Xing, J; Yang, Q; Zheng, X; Zou, Y | 1 |
John, J; Suryalatha, K; Thomas, S | 1 |
Hsueh, PR; Jean, SS; Lee, WS; Liao, CH; Sheng, WH | 1 |
Cai, H; Shen, Q; Shen, Y; Yang, Q; Zhang, Y; Zhou, H; Zhou, J | 1 |
Aynioglu, A; Hacihanefioglu, A; Mutlu, B | 1 |
An, R; Du, Z; Gao, C; Sun, Z; Tong, J; Yu, K | 1 |
Koomanachai, P; Thamlikitkul, V; Tongsai, S | 1 |
Fujiwara, H; Hasegawa, N; Iwasaki, E; Iwata, S; Nishimura, T; Sugita, K; Uwamino, Y | 1 |
Bhaskar, MM; Kumaravel, S; Sistla, S | 1 |
Li, P; Wang, W; Wang, X; Zhao, X | 1 |
Gao, L; Li, Y; Lyu, Y | 1 |
Ali, I; Shabbir, M | 1 |
Du, L; Long, Y; Shi, H; Shi, L; Sun, L; Wang, H; Xu, H; Zhen, Y; Zhu, J; Zou, B | 1 |
Chen, XK; Dong, Q; Hao, GX; Huang, X; Li, Y; Shi, HY; Wu, XJ; Zhao, W; Zheng, Y | 1 |
Chen, H; Li, S; Niu, DK; Wang, H; Wang, Q; Yin, Y | 1 |
Chen, Y; Fu, Y; Hua, X; Ji, S; Jiang, Y; Lan, P; Ruan, Z; Xu, Q; Yang, Y; Yu, Y | 1 |
Fu, L; Qin, Y; Wu, L; Xue, X; Zhang, D; Zhang, J | 1 |
Cai, Y; Wang, J; Wang, R; Yang, D | 1 |
Cyriac, SL; Dubashi, B; Harish, BH; Jadhav, N; Jaffa, E; Kayal, S; Matta, KK; Pattnaik, J; Pillai, US; Ponraj, M; Prakash, B; Ranjith, K; Singh, J | 1 |
Guo, Q; Hu, F; Li, Y; Su, J; Wang, M; Wu, S; Xu, S | 1 |
Chang, DM; Chen, HC; Huang, ZH; Lin, SY; Lu, CC | 1 |
Ejaz, A; Ejaz, H; Javed, H; Saleem, R; Younas, S; Zafar, A | 1 |
Cao, L; Chen, H; Chen, J; Deng, L; Hu, Z; Li, Q; Lu, X; Mao, X; Rao, C; Tang, M | 1 |
Chen, YH; Chen, YS; Chuang, YC; Huang, CT; Ko, WC; Lee, WS; Lin, HH; Lin, JC; Liu, JW; Liu, YC; Lu, MC; Tang, HJ; Wang, FD | 2 |
Chen, C; Li, M; Liu, W; Song, Q; Tan, Y; Xiao, J | 1 |
Kong, L; Meng, L; Qi, B; Wu, C; Wu, X | 1 |
Carvalhaes, CG; Castanheira, M; Flamm, RK; Sader, HS; Streit, JM | 1 |
Li, LJ; Wang, DL; Zhao, LD; Zhou, MJ | 1 |
Li, X; Lu, C; Sun, S; Wang, D; Wang, Y | 1 |
Dong, D; Li, J; Li, S; Liu, Y; Su, N; Sun, X; Tan, J; Wang, W; Wu, G; Wu, Y; Xiong, W; Yu, C; Zhang, R; Zong, Z; Zou, K | 1 |
Wu, F; Zhou, X | 1 |
Dang, ZL; Li, B; Qin, HY; Rao, Z; Wei, YH; Wu, XA; Zhu, L | 1 |
Chang, SP; Lai, CC; Lan, SH; Lu, LC; Tang, HJ | 1 |
Guclu, E; Karabay, O; Kaya, G; Ogutlu, A | 1 |
Chen, L; Dong, H; Dong, Y; Hao, R; Li, Y; Liu, L; Meng, T; Wang, X; Xie, J | 1 |
Gao, W; Lu, H; Wang, H; Wu, G; Yang, C; Yuan, C | 1 |
Chen, L; Deng, Y; Lv, Q; Ruan, J; Zhu, X | 1 |
Fukushima, Y; Murabayashi, H; Nakajima, C; Ohkoshi, Y; Sakai, K; Sato, T; Suzuki, Y; Takakuwa, Y; Yokota, SI | 1 |
Fang, Q; Fang, XL; Hu, J; Lai, YX; Xiao, YH; Zheng, Y | 1 |
Attwood, M; Bowker, K; MacGowan, A; Noel, A | 1 |
Abdul Momin, MHF; Hornsey, M; Phee, LM; Standing, JF; Wareham, DW | 1 |
Aggarwal, A; Sahu, C; Thomas, KN | 1 |
Huang, J; Jiang, C; Liu, Z; Zhu, X | 1 |
Ku, YH; Yu, WL | 1 |
Brewster, JT; Han, HH; He, XP; Hu, XL; Lynch, VM; Mangel, DN; Sedgwick, AC; Sessler, JL; Shang, Y; Snelson, DW; Steinbrueck, A; Tian, H; Yan, KC | 1 |
Cao, J; Chen, L; Liao, W; Xu, W; Xu, Y; Yu, K; Zeng, W; Zhou, T | 1 |
Fang, X; Xuan, J; Yang, Y; Yao, J; Zhang, Q | 1 |
Chang, SP; Chao, CM; Lai, CC; Lan, SH; Lu, LC | 1 |
Chen, Y; Liu, L; Xiang, Q | 1 |
Dong, J; Li, Z; Luo, S; Pu, C; Wang, Z; Xing, Y; Yang, Z | 1 |
Chen, CH; Chen, CM; Chen, WC; Fang, WF; Fu, PK; Huang, CT; Ku, SC; Kuo, LK; Lai, CC; Tu, CY; Wang, YT | 1 |
Khalim, W; Mwesigye, J; Tungotyo, M; Twinomujuni, SS | 1 |
Huang, M; Wang, Q; Zhou, S | 1 |
Fang, X; Huang, F; Wang, J; Yu, J | 1 |
Chen, ZG; Feng, DY; Kuang, SF; Li, H; Li, X; Peng, B; Peng, XX; Wu, WB; Zhang, TT | 1 |
Gkeka, I; Kassomenaki, A; Kourti, A; Mantzana, P; Meletis, G; Protonotariou, E; Skoura, L; Tychala, A; Vlachodimou, N | 1 |
Guan, YY; Jin, HB; Yang, J; Zheng, L | 1 |
Han, Z; Shen, S; Xiong, Z; Zeng, D | 1 |
Cai, S; Chen, Y; DU, G; Gao, X; Huang, H; Kong, J; Luo, J; Song, D; Wei, F; Yang, L; Zhang, K | 1 |
Mo, L; Peng, M; Qian, J; Wang, J | 1 |
Cao, Y; Liu, C; Ren, H; Shang, Z; Wang, R; Xie, L; Yang, Y; Zhang, J | 1 |
Chang, Q; Ding, L; He, X; Huang, W; Li, X; Wan, X | 1 |
Fan, K; Lu, J; Ren, Y; Shao, X; Sun, H; Tian, X; Wei, J; Xie, N | 1 |
Liu, H; Yang, M; Yang, Z | 1 |
Chen, CH; Chen, CM; Chen, WC; Cheng, WC; Fang, WF; Fu, PK; Ku, SC; Kuo, LK; Lai, CC; Tu, CY; Wang, YT | 1 |
Huang, D; Huang, F; Huang, L; Xie, L; Xu, J; Zhan, Z; Zhang, A; Zhao, M; Zhou, Q | 1 |
Bai, H; Han, X; Li, H; Nie, X; Peng, L; Wang, J; Yao, Y | 1 |
Gu, C; Lin, C; Tan, M; Wang, D; Wang, S; Wu, Y | 1 |
13 review(s) available for cefoperazone and sulbactam
Article | Year |
---|---|
[Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. c. Combinations of beta-lactam antibiotics and beta-lactamases inhibitors].
Topics: Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Penicillanic Acid; Penicillins; Respiratory Tract Infections; Sulbactam; Ticarcillin | 1987 |
[Sulperazone--a combined form of cefoperazone with sulbactam].
Topics: Anti-Infective Agents, Urinary; Cefoperazone; Clinical Trials as Topic; Drug Combinations; Humans; Microbial Sensitivity Tests; Sulbactam | 1995 |
beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefoperazone; Drug Therapy, Combination; Enzyme Inhibitors; Microbial Sensitivity Tests; Sulbactam | 1997 |
Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem.
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Cefoperazone; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Sulbactam | 2002 |
Salmonella group C necrotizing fasciitis: a case report and review of the literature.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefoperazone; Child, Preschool; Combined Modality Therapy; Diagnosis, Differential; Fasciitis, Necrotizing; Female; Humans; Lupus Erythematosus, Systemic; Male; Risk Factors; Salmonella; Salmonella Infections; Sulbactam | 2006 |
Sulbactam-containing beta-lactamase inhibitor combinations.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Sulbactam | 2008 |
[Modern possibilities of hepacef combi (cefoperazon/sulbactam) application for the treatment of surgical infection].
Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Combinations; Humans; Sulbactam; Surgical Wound Infection | 2011 |
A case of pyogenic liver abscess infected with Fusobacterium necrophorum depicted by microscopy and confirmed by tissue culture.
Topics: Adult; Cefoperazone; Fusobacterium Infections; Fusobacterium necrophorum; Humans; Infusions, Intravenous; Liver Abscess, Pyogenic; Male; Microscopy; Sulbactam; Tissue Culture Techniques | 2011 |
Acute purulent pericarditis following staged percutaneous coronary intervention for multivessel disease.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Cefoperazone; Combined Modality Therapy; Coronary Artery Disease; Drainage; Drug Combinations; Female; Humans; Percutaneous Coronary Intervention; Pericarditis; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam; Treatment Outcome | 2013 |
Efficacy and safety of cefoperazone-sulbactam in empiric therapy for febrile neutropenia: A systemic review and meta-analysis.
Topics: Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Febrile Neutropenia; Humans; Sulbactam | 2020 |
Cefoperazone/sulbactam: New composites against multiresistant gram negative bacteria?
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefoperazone; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Sulbactam | 2021 |
Clinical Efficacy and Safety of Cefoperazone-Sulbactam in Treatment of Intra-Abdominal Infections: A Systematic Review and Meta-Analysis.
Topics: Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Humans; Intraabdominal Infections; Sulbactam; Treatment Outcome | 2021 |
Cefoperazone and sulbactam-related eosinophilic peritonitis: a case report and literature review.
Topics: Anti-Bacterial Agents; Cefoperazone; Female; Humans; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Sulbactam | 2021 |
56 trial(s) available for cefoperazone and sulbactam
Article | Year |
---|---|
Multicentre study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-sulbactam and other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Cefoperazone; Drug Combinations; Drug Resistance, Microbial; Microbial Sensitivity Tests; Sulbactam | 1992 |
[An evaluation of combination antibiotic therapy in infections with hematological disorders. Hyogo Cooperative Study Group of Infectious Diseases Complicating Hematological Disorders].
Topics: Adult; Bacterial Infections; Cefoperazone; Child; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Male; Sulbactam | 1991 |
[In vitro activity of beta-lactam antibiotics in combination with sulbactam against enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter. Results of a multicenter study].
Topics: Acinetobacter; Cefoperazone; Cefotaxime; Ceftazidime; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enterobacteriaceae; Humans; In Vitro Techniques; Mezlocillin; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Ticarcillin | 1991 |
[Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefoperazone; Drug Compounding; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Sulbactam | 1991 |
A randomized clinical study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intra-abdominal infections.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefoperazone; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Sulbactam | 1990 |
[Clinical evaluation of sulbactam/cefoperazone in lower respiratory tract infections].
Topics: Adult; Aged; Aged, 80 and over; Cefoperazone; Clinical Trials as Topic; Drug Combinations; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Respiratory Tract Infections; Sulbactam | 1990 |
Preventing major operative site infection after radical abdominal hysterectomy and pelvic lymphadenectomy.
Topics: Adult; Bacteria; beta-Lactamases; Cefoperazone; Female; Humans; Hysterectomy; Infusions, Intravenous; Lymph Node Excision; Middle Aged; Premedication; Prospective Studies; Random Allocation; Sulbactam; Surgical Wound Infection; Uterine Cervical Neoplasms | 1989 |
[Clinical assessment of sulbactam/cefoperazone in comparison with ceftizoxime in patients with postoperative infections by well controlled method].
Topics: Adolescent; Adult; Aged; beta-Lactamase Inhibitors; Cefoperazone; Cefotaxime; Ceftizoxime; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Penicillanic Acid; Sulbactam; Surgical Wound Infection | 1985 |
[Microorganisms isolated from urinary tract infection and their beta-lactamase production and evaluation of clinical efficacy of sulperazone].
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Bacteria; beta-Lactamases; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multicenter Studies as Topic; Sulbactam; Urinary Tract Infections | 1988 |
Multiple-dose pharmacokinetics and toleration of intravenously administered cefoperazone and sulbactam when given as single agents or in combination.
Topics: Adult; Cefoperazone; Drug Combinations; Humans; Infusions, Intravenous; Male; Random Allocation; Sulbactam | 1988 |
Pharmacokinetics and pharmacodynamics of cefoperazone-sulbactam in patients on continuous ambulatory peritoneal dialysis.
Topics: Adult; Aged; Aged, 80 and over; Bacteria; Cefoperazone; Drug Combinations; Humans; Infusions, Intravenous; Infusions, Parenteral; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Random Allocation; Sulbactam | 1988 |
[Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Infant; Male; Penicillanic Acid; Sulbactam | 1984 |
[A combined consecutive therapy with fosfomycin and sulbactam/cefoperazone for bacterial infections associated with hematological diseases].
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefoperazone; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Fosfomycin; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Injections, Intravenous; Male; Middle Aged; Sulbactam | 1995 |
[Clinical efficacy of sulbactam/cefoperazone for the treatment of geriatric patients with respiratory tract infections].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Respiratory Tract Infections; Sulbactam | 1995 |
[Use of a combination of cefoperazone with sulbactam for treatment of patients with wound infections].
Topics: Adolescent; Adult; Aged; Cefoperazone; Drug Combinations; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sulbactam; Wound Infection | 1994 |
Comparison of cefoperazone plus sulbactam with clindamycin plus gentamicin as treatment for intra-abdominal infections.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefoperazone; Chi-Square Distribution; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sulbactam; Superinfection; Treatment Failure | 1994 |
[Laboratory and clinical studies on combined effects of fosfomycin plus sulbactam/cefoperazone for mixed infections of MRSA and Pseudomonas aeruginosa].
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Dibekacin; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Methicillin Resistance; Middle Aged; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Vancomycin | 1994 |
[Clinical evaluation of sulbactam/cefoperazone for infections during the chemotherapy of hematologic malignancy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Agents; Bacterial Infections; Cefoperazone; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Leukemia; Male; Middle Aged; Sulbactam | 1994 |
[Clinical evaluation of combination therapy of sulbactam/cefoperazone and aminoglycoside in respiratory tract infections].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bronchitis; Cefoperazone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia; Respiratory Tract Infections; Sulbactam; Tobramycin | 1994 |
An open trial of cefoperazone plus sulbactam for the treatment of fever in cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Bacterial Infections; Cefoperazone; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Sulbactam | 1993 |
[Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Cefoperazone; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Middle Aged; Sulbactam | 1993 |
[Multicenter study of the effects of sulbactam/cefoperazone on bacterial infections in the fields of internal medicine focused mainly on respiratory infections in Tochigi Prefecture].
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefoperazone; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Sulbactam | 1993 |
[An evaluation of a therapy with antibacterial and antifungal agents infections with hematological disorders].
Topics: Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Fluconazole; Hematologic Diseases; Humans; Immunocompromised Host; Infant; Male; Middle Aged; Pneumonia; Sepsis; Sulbactam | 1993 |
[A randomized controlled clinical trial of sulperazone as compared with cefotaxime in the treatment of bacterial infections].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cefotaxime; Drug Combinations; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sulbactam | 1995 |
Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefoperazone; Drug Therapy, Combination; Humans; Imipenem; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam; Vancomycin | 1996 |
[Clinical study on sulbactam/cefoperazone in urinary tract infections in elderly patients].
Topics: Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Bacterial Infections; Cefoperazone; Drug Combinations; Female; Humans; Kidney Pelvis; Male; Middle Aged; Nephritis; Sulbactam; Urinary Tract Infections | 1996 |
[Clinical evaluation of sulbactam/cefoperazone for lower respiratory tract infections. Correlation between the efficacy of sulbactam/cefoperazone and beta-lactamase].
Topics: Aged; Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefoperazone; Drug Therapy, Combination; Female; Humans; Male; Respiratory Tract Infections; Sputum; Sulbactam | 1996 |
Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Skin Diseases, Bacterial; Sulbactam; Urinary Tract Infections | 1997 |
Randomized comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Cefoperazone; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sulbactam; Superinfection | 1998 |
[A randomized controlled clinical trial of sulperazon in the treatment of surgical infection].
Topics: Adult; Aged; Anti-Bacterial Agents; Cefoperazone; Drug Combinations; Female; Humans; Male; Middle Aged; Sulbactam; Surgical Wound Infection | 1996 |
[A randomized clinical study of sulperazone versus tienam in the treatment of LRTIS].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bronchitis; Cefoperazone; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia; Sulbactam; Thienamycins | 1996 |
Cefoperazone/sulbactam + co-trimoxazole vs ceftazidime + co-trimoxazole in the treatment of severe melioidosis: a randomized, double-blind, controlled study.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Ceftazidime; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Melioidosis; Middle Aged; Prospective Studies; Statistics, Nonparametric; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
[Efficacy and safety of sulbactam/cefoperazone for hepato-biliary infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefoperazone; Cholangitis; Cholecystitis; Drug Combinations; Enterococcus; Female; Humans; Klebsiella Infections; Liver Abscess; Male; Middle Aged; Neoplasms; Pseudomonas Infections; Sulbactam; Treatment Outcome | 1997 |
[The empirical antibiotic therapy of patients with acute leukemias: the results of a multicenter study].
Topics: Acute Disease; Adult; Ampicillin; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Therapy, Combination; Fever of Unknown Origin; Fluconazole; Gentamicins; Humans; Leukemia; Russia; Sulbactam; Time Factors; Ukraine | 1998 |
[Clinical efficacy of fosfomycin in combination with sulbactam/cefoperazone in the treatment of severe infections complicated to blood dyscrasia. Working Group of Kanto Combination Therapy for FOM + SBT/CPZ].
Topics: Anti-Bacterial Agents; Cefoperazone; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Fosfomycin; Hematologic Diseases; Humans; Infections; Sulbactam | 1998 |
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Cefoperazone; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam | 1999 |
Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis.
Topics: Adult; Aged; Anti-Bacterial Agents; Burkholderia pseudomallei; Cefoperazone; Ceftazidime; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Melioidosis; Middle Aged; Prospective Studies; Sulbactam; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2001 |
[Comparative clinical and epidemiological evaluation of beta-lactam antibiotics in the treatment of intraabdominal infections].
Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cefoperazone; Cephalosporins; Clinical Trials as Topic; Costs and Cost Analysis; Drug Combinations; Humans; Imipenem; Meropenem; Models, Economic; Sulbactam; Thienamycins | 2003 |
[Efficacy and safety of cefoperazone/sulbactam in the treatment of children with mucoviscidosis during exacerbation of the bronchopulmonary process].
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefoperazone; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Treatment Outcome | 2003 |
[Clinical and bacteriological substantiation of the use of cefoperazone/sulbactam in complex therapy of patients with pyo-destructive forms of lower respiratory tract infection (LRTI)].
Topics: Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Sulbactam | 2004 |
[Comparison of efficacy between ceftriaxone and cefoperazone plus sulbactam in peri-operative treatment of acute suppurative cholangitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefoperazone; Ceftriaxone; Cholangitis; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Perioperative Care; Postoperative Period; Prospective Studies; Sulbactam; Suppuration | 2004 |
[Therapeutic effects of cefepime and sulbactam/cefoperazone on moderate and severe respiratory tract infection in children].
Topics: Anti-Bacterial Agents; Cefepime; Cefoperazone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Pneumonia, Bacterial; Sulbactam | 2005 |
Cost-effectiveness study comparing cefoperazone-sulbactam to a three-drug combination for treating intraabdominal infections in an Indian health-care setting.
Topics: Abdomen; Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Ceftazidime; Cost-Benefit Analysis; Drug Therapy, Combination; Economics, Pharmaceutical; Female; Humans; India; Male; Metronidazole; Middle Aged; Sulbactam; Treatment Outcome | 2008 |
Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Child; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Male; Metronidazole; Middle Aged; Peritonitis; Sulbactam; Treatment Failure; Treatment Outcome | 2008 |
Bioequivalence study of the two 1.5 g cefoperazone and sulbactam IM injections in Thai healthy male volunteers.
Topics: Adult; Analysis of Variance; Anti-Bacterial Agents; Area Under Curve; Cefoperazone; Chromatography, High Pressure Liquid; Confidence Intervals; Cross-Over Studies; Double-Blind Method; Humans; Infusions, Intravenous; Male; Sulbactam; Thailand; Therapeutic Equivalency | 2008 |
Comparison of sulbactam-cefoperazone with carbapenems as empirical monotherapy for febrile neutropenic children with lymphoma and solid tumors.
Topics: Adolescent; Carbapenems; Cefoperazone; Child; Child, Preschool; Female; Humans; Infant; Lymphoma; Male; Neutropenia; Sarcoma; Sulbactam | 2011 |
Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia.
Topics: Adolescent; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Time Factors | 2012 |
Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Sulbactam; Tazobactam | 2013 |
A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; Cefoperazone; Ceftriaxone; Female; Humans; Injections, Intravenous; Male; Middle Aged; Respiratory Tract Infections; Sulbactam; Treatment Outcome; Urinary Tract Infections; Young Adult | 2013 |
Drug concentrations in the serum and cerebrospinal fluid of patients treated with cefoperazone/sulbactam after craniotomy.
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Cefoperazone; Craniotomy; Drug Combinations; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Serum Bactericidal Test; Sulbactam; Time Factors | 2015 |
A comparison of the efficacy of piperacillin-tazobactam and cefoperazone-sulbactam therapies in the empirical treatment of patients with febrile neutropenia.
Topics: Adult; Aged; Antineoplastic Agents; Cefoperazone; Drug Combinations; Drug Eruptions; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Leukocyte Count; Male; Middle Aged; Neutrophils; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sulbactam; Treatment Outcome; Young Adult | 2016 |
Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration.
Topics: Acinetobacter baumannii; Adult; Aged; Anti-Bacterial Agents; Cefoperazone; Critical Illness; Female; Hemofiltration; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Sulbactam; Young Adult | 2016 |
Comparison of the treatment efficacy between tigecycline plus high-dose cefoperazone-sulbactam and tigecycline monotherapy against ventilator-associated pneumonia caused by extensively drug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Cefoperazone; Cohort Studies; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia, Ventilator-Associated; Prospective Studies; Sulbactam; Tigecycline; Treatment Outcome | 2018 |
Cefepime vs. cefoperazone/sulbactam in combination with amikacin as empirical antibiotic therapy in febrile neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Cefepime; Cefoperazone; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Sulbactam; Survival Analysis; Withholding Treatment; Young Adult | 2018 |
Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cefoperazone; Drug Therapy, Combination; Female; Haemophilus Infections; Healthcare-Associated Pneumonia; Humans; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas Infections; Sulbactam; Treatment Outcome | 2019 |
Effectiveness of Cefoperazone-sulbactam alone and Combined with Tigecycline in the Treatment of Multi-drug Resistant Acinetobacter Baumannii Pulmonary Infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Cefoperazone; China; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Sulbactam; Tigecycline; Treatment Outcome | 2020 |
271 other study(ies) available for cefoperazone and sulbactam
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea | 2010 |
[Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefoperazone; Drug Synergism; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Male; Middle Aged; Opportunistic Infections; Piperacillin; Pneumonia; Sepsis; Sulbactam | 1992 |
Fatal pneumonia caused by Corynebacterium group JK after treatment of Staphylococcus aureus pneumonia.
Topics: Aged; Cefoperazone; Corynebacterium; Corynebacterium Infections; Disease Susceptibility; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Immunocompromised Host; Kidney Failure, Chronic; Male; Minocycline; Opportunistic Infections; Pneumonia; Pneumonia, Staphylococcal; Sulbactam | 1992 |
Error rates in cefoperazone and cefoperazone-sulbactam disk tests with Enterobacteriaceae and Pseudomonas aeruginosa.
Topics: Agar; Cefoperazone; Culture Media; Drug Combinations; Drug Resistance, Microbial; Enterobacteriaceae; False Positive Reactions; Microbial Sensitivity Tests; Penicillin Resistance; Predictive Value of Tests; Pseudomonas aeruginosa; Reproducibility of Results; Sensitivity and Specificity; Sulbactam | 1992 |
Activity of sulbactam combinations against Escherichia coli isolates with known amounts of TEM-1 beta-lactamase.
Topics: Ampicillin; beta-Lactamases; Cefoperazone; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Microbial Sensitivity Tests; Sulbactam | 1992 |
Effect of impaired renal function on the pharmacokinetics of coadministered cefoperazone and sulbactam.
Topics: Adolescent; Adult; Aged; Cefoperazone; Drug Combinations; Female; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Sulbactam | 1992 |
Use of a predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbactam.
Topics: Bacteria; Cefoperazone; Drug Resistance, Microbial; Drug Therapy, Combination; Microbial Sensitivity Tests; Predictive Value of Tests; Quality Control; Regression Analysis; Sulbactam | 1992 |
Syndrome of inappropriate secretion of antidiuretic hormone associated with multiple sclerosis.
Topics: Cefoperazone; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Multiple Sclerosis; Sulbactam; Supraoptic Nucleus | 1992 |
[Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
Topics: Anti-Infective Agents, Urinary; Bacterial Infections; Cefoperazone; Drug Combinations; Drug Evaluation; Escherichia coli; Extracellular Space; Humans; Male; Microbial Sensitivity Tests; Prostate; Prostatitis; Staphylococcus epidermidis; Sulbactam | 1991 |
[The effect of some antibiotics on primary antibody response].
Topics: Ampicillin; Animals; Antibody Formation; Cefoperazone; Drug Therapy, Combination; Mezlocillin; Rabbits; Rifamycins; Sulbactam | 1991 |
[A case of acute bacterial prostatitis caused by gram positive cocci].
Topics: Acute Disease; Adult; Cefoperazone; Drug Combinations; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Male; Prostatitis; Sulbactam | 1991 |
Susceptibilities of anaerobic gram-negative bacilli to thirteen antimicrobials and beta-lactamase inhibitor combinations.
Topics: Ampicillin; Anti-Bacterial Agents; Antiprotozoal Agents; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Anaerobic Bacteria; Microbial Sensitivity Tests; Sulbactam; Ticarcillin | 1991 |
[Enhancement of susceptibility of sulbactam/cefoperazone-treated bacteria to phagocytes].
Topics: Cefoperazone; Escherichia coli; Microbial Sensitivity Tests; Phagocytosis; Sulbactam | 1991 |
Influence of beta-lactamase inhibitors on the potency of their companion drug with organisms possessing class I enzymes.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Enzyme Induction; Mice; Microbial Sensitivity Tests; Sulbactam; Ticarcillin | 1991 |
Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefamandole; Cefoperazone; Cephalothin; Daptomycin; Disease Models, Animal; Female; Glycopeptides; Oxacillin; Peptides; Rabbits; Staphylococcal Infections; Sulbactam; Teicoplanin; Vancomycin | 1990 |
Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefoperazone; Ciprofloxacin; Clindamycin; Clostridium Infections; Clostridium perfringens; Drug Therapy, Combination; Female; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Peptostreptococcus; Prevotella melaninogenica; Rabbits; Sulbactam | 1990 |
In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinations.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Cefoperazone; Drug Interactions; Drug Therapy, Combination; Gentamicins; Immunoenzyme Techniques; Netilmicin; Piperacillin; Sulbactam; Tobramycin | 1991 |
[Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. II. In vitro combined effects of sulbactam/cefoperazone with imipenem/cilastatin, cefuzonam, flomoxef, amikacin or tobramycin].
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Cefoperazone; Ceftizoxime; Cephalosporins; Cilastatin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Sulbactam; Tobramycin | 1991 |
In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters.
Topics: Bacteria; Cefoperazone; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Microbial Sensitivity Tests; Sulbactam | 1990 |
[Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. I. Effect of sulbactam against beta-lactams resistant strains and in vitro combined effect of sulbactam/cefoperazone with each of pipera
Topics: Anti-Bacterial Agents; Bacteria; Cefoperazone; Ceftazidime; Doxycycline; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Fosfomycin; Moxalactam; Piperacillin; Sulbactam | 1990 |
[Clinical experience with chemotherapy using sulbactam/cefoperazone for severe infections accompanying malignant hematological disorders].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefoperazone; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Male; Middle Aged; Opportunistic Infections; Sulbactam | 1990 |
[Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
Topics: Ampicillin; Ampicillin Resistance; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Drug Resistance, Microbial; Drug Synergism; Microbial Sensitivity Tests; Penicillin Resistance; Sulbactam | 1990 |
In vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci.
Topics: Ampicillin; Cefoperazone; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Oxacillin; Sodium Chloride; Staphylococcus; Sulbactam | 1990 |
[Activity of cefoperazone and cefoperazone-sulbactam against gram-positive and gram-negative bacteria].
Topics: Cefoperazone; Drug Combinations; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Sulbactam | 1990 |
Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillins; Piperacillin; Sulbactam; Ticarcillin | 1990 |
Antimicrobial activity of cefoperazone with clavulanic acid or sulbactam against Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Microbial Sensitivity Tests; Sulbactam | 1990 |
In vitro activity of cefoperazone-sulbactam combinations against cefoperazone-resistant clinical bacterial isolates.
Topics: Acinetobacter; Bacteria; Bacteroides; Cefoperazone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Humans; Pseudomonas; Sulbactam | 1989 |
[Diffusion of sulbactam and cefoperazone into the prostatic tissue].
Topics: Aged; Aged, 80 and over; Cefoperazone; Humans; Male; Middle Aged; Prostate; Sulbactam | 1989 |
The compatibility of nicardipine hydrochloride injection with various ICU medications during simulated Y-site injection.
Topics: Ampicillin; Cefoperazone; Chemistry, Pharmaceutical; Drug Incompatibility; Humans; Infusions, Intravenous; Intensive Care Units; Nicardipine; Sulbactam | 1989 |
[Effects of sulbactam on the activity of cefoperazone against various clinical isolates].
Topics: Bacteria; Cefoperazone; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Penicillin Resistance; Sulbactam | 1989 |
[Effects of sulbactam/cefoperazone in patients with respiratory infections in aged and/or with underlying respiratory diseases].
Topics: Aged; Cefoperazone; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Respiratory Tract Infections; Sulbactam | 1989 |
[Treatment with sulbactam/cefoperazone of severe infections in patients with hematological disorders].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefoperazone; Drug Therapy, Combination; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Sulbactam | 1989 |
[Passage into the human milk and clinical evaluation of sulbactam/cefoperazone].
Topics: Adolescent; Adult; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Infusions, Parenteral; Injections, Intravenous; Milk, Human; Penicillanic Acid; Pregnancy; Sulbactam | 1985 |
High-performance liquid chromatographic assay of sulbactam using pre-column reaction with 1,2,4-triazole.
Topics: Animals; Cefoperazone; Chromatography, High Pressure Liquid; Kinetics; Male; Penicillanic Acid; Penicillins; Rats; Rats, Inbred Strains; Spectrophotometry, Ultraviolet; Sulbactam; Triazoles | 1985 |
The cefoperazone-sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefoperazone; Drug Stability; Drug Therapy, Combination; Enterobacteriaceae; Enzyme Inhibitors; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillanic Acid; Staphylococcus; Sulbactam | 1985 |
Cefoperazone and cefoperazone-sulbactam susceptibility tests with anaerobic bacteria by the thioglycolate disk elution method.
Topics: Bacteria, Anaerobic; Cefoperazone; Drug Combinations; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Thioglycolates | 1985 |
In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and beta-lactamase studies.
Topics: Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Cephalosporins; Drug Combinations; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam | 1985 |
In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.
Topics: Amoxicillin; Ampicillin; Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Penicillanic Acid; Penicillins; Sulbactam; Ticarcillin | 1986 |
High-pressure liquid chromatographic assay of sulbactam in plasma, urine, and tissue.
Topics: Cefoperazone; Chromatography, High Pressure Liquid; Humans; Male; Penicillanic Acid; Prospective Studies; Prostate; Random Allocation; Sulbactam; Tissue Distribution | 1986 |
In-vitro activity of cefoperazone-sulbactam against Bacteroides species.
Topics: Bacteria, Anaerobic; Bacteroides; beta-Lactamases; Cefoperazone; Drug Interactions; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam | 1986 |
Placental transfer of cefoperazone and sulbactam in the isolated in vitro perfused human placenta.
Topics: Biological Transport; Cefoperazone; Female; Humans; In Vitro Techniques; Placenta; Sulbactam | 1988 |
[Clinical laboratory approach for estimating effective administrative dose of sulbactam/cefoperazone].
Topics: Bacteria; Cefoperazone; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Predictive Value of Tests; Sulbactam | 1988 |
[Transfer of injected sulbactam/cefoperazone into burn blister fluid].
Topics: Blister; Burns; Cefoperazone; Drug Combinations; Exudates and Transudates; Humans; Injections, Intravenous; Models, Biological; Sulbactam | 1988 |
Cefoperazone-sulbactam combination in the treatment of urinary tract infections: efficacy, safety, and effects on coagulation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation; Cefoperazone; Drug Combinations; Drug Evaluation; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Recurrence; Sulbactam; Urinary Tract Infections | 1987 |
Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination.
Topics: Bacteria, Anaerobic; Bacteroides; Cefoperazone; Drug Combinations; Enterobacteriaceae; Gram-Negative Bacteria; Microbial Sensitivity Tests; Pseudomonas; Quality Control; Sulbactam | 1988 |
In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides; Bacteroides fragilis; Cefoperazone; Clostridium; Fusobacterium; Gram-Positive Bacteria; Microbial Sensitivity Tests; Sulbactam | 1988 |
Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.
Topics: Adult; Aged; Cefoperazone; Female; Humans; Infusions, Intravenous; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Sulbactam | 1988 |
Multiple-dose pharmacokinetics of intravenously administered cefoperazone and sulbactam when given in combination to infected, seriously ill, elderly patients.
Topics: Abdomen; Aged; Bacterial Infections; Cefoperazone; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Mathematics; Middle Aged; Sulbactam | 1988 |
[Antimicrobial activity of sulbactam/cefoperazone. Comparison with other new cephems].
Topics: Bacteria; Cefoperazone; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Sulbactam | 1987 |
In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination.
Topics: Bacteria; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Synergism; Humans; Microbial Sensitivity Tests; Sulbactam | 1987 |
Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria.
Topics: Bacteria, Aerobic; Bacteroides fragilis; beta-Lactamase Inhibitors; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Microbial Sensitivity Tests; Sulbactam | 1987 |
[Clinical studies on sulbactam/cefoperazone in pediatric field].
Topics: Age Factors; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child, Preschool; Drug Combinations; Drug Evaluation; Female; Humans; Infant; Infusions, Parenteral; Injections, Intravenous; Male; Penicillanic Acid; Sulbactam | 1984 |
[Clinical experience on sulbactam/cefoperazone in the pediatric field].
Topics: Adolescent; Age Factors; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Female; Humans; Infant; Injections, Intravenous; Male; Penicillanic Acid; Respiratory Tract Infections; Sulbactam | 1984 |
[Clinical studies of sulbactam/cefoperazone therapy in pediatric bacterial infections].
Topics: Age Factors; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Injections, Intravenous; Male; Penicillanic Acid; Sulbactam | 1984 |
[Clinical study on sulbactam/cefoperazone in the field of pediatrics].
Topics: Acute Disease; Age Factors; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Female; Humans; Infant; Male; Penicillanic Acid; Respiratory Tract Infections; Sulbactam | 1984 |
[Clinical studies on sulbactam/cefoperazone in the pediatric field].
Topics: Age Factors; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Female; Humans; Infant; Injections, Intravenous; Male; Penicillanic Acid; Sulbactam | 1984 |
[Clinical evaluation of sulbactam/cefoperazone in the pediatric infections].
Topics: Adolescent; Age Factors; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Female; Humans; Infant; Male; Penicillanic Acid; Sulbactam | 1984 |
[Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
Topics: Age Factors; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Penicillanic Acid; Sulbactam | 1984 |
[Experimental and clinical studies of sulbactam/cefoperazone in pediatric field].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Half-Life; Humans; Infant; Male; Penicillanic Acid; Sulbactam | 1984 |
[Studies on sulbactam/cefoperazone in the field of pediatrics].
Topics: Acute Disease; Adolescent; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Penicillanic Acid; Sulbactam | 1984 |
[Laboratory and clinical studies of sulbactam/cefoperazone in the pediatric field].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Kinetics; Male; Penicillanic Acid; Sulbactam | 1984 |
[Basic and clinical studies of sulbactam/cefoperazone in pediatric field].
Topics: Abscess; Adolescent; Age Factors; Animals; Bacterial Infections; beta-Lactamase Inhibitors; Blepharitis; Cefoperazone; Drug Combinations; Female; Humans; Meningitis; Penicillanic Acid; Rabbits; Staphylococcal Infections; Sulbactam | 1984 |
[Clinical and bacteriological efficiency of sulbactam/cefoperazone in gynecological infectious diseases].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Infusions, Parenteral; Middle Aged; Penicillanic Acid; Pregnancy; Sulbactam | 1984 |
[Clinical evaluation of sulbactam/cefoperazone in obstetric and gynecological infection].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Infusions, Parenteral; Middle Aged; Penicillanic Acid; Pregnancy; Pregnancy Complications, Infectious; Sulbactam | 1984 |
[Clinical evaluation of sulbactam/cefoperazone for infections in the field of obstetrics and gynecology].
Topics: Abortion, Induced; Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Infusions, Parenteral; Middle Aged; Penicillanic Acid; Postoperative Complications; Pregnancy; Sulbactam | 1984 |
[Experience with sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adolescent; Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Penicillanic Acid; Sulbactam | 1984 |
[Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Exudates and Transudates; Female; Genital Diseases, Female; Genitalia, Female; Humans; Middle Aged; Penicillanic Acid; Sulbactam; Tissue Distribution | 1984 |
[Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adnexa Uteri; Adult; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Exudates and Transudates; Female; Humans; Pelvic Inflammatory Disease; Penicillanic Acid; Peritonitis; Sulbactam; Uterus | 1984 |
[Clinical trial of sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Middle Aged; Penicillanic Acid; Sulbactam | 1984 |
[Clinical evaluation of sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adolescent; Adult; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Middle Aged; Penicillanic Acid; Sulbactam | 1984 |
[Clinical studies of sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Middle Aged; Penicillanic Acid; Sulbactam | 1984 |
[Fundamental and clinical studies of sulbactam/cefoperazone in the field of pediatrics].
Topics: Adolescent; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Injections, Intravenous; Male; Penicillanic Acid; Sulbactam | 1984 |
[Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Injections, Intravenous; Penicillanic Acid; Pregnancy; Sulbactam | 1984 |
[Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Exudates and Transudates; Female; Genital Diseases, Female; Humans; Injections, Intravenous; Kinetics; Models, Biological; Pelvis; Penicillanic Acid; Pregnancy; Sulbactam | 1984 |
[Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Injections, Intravenous; Penicillanic Acid; Pregnancy; Sulbactam | 1984 |
[Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Infusions, Parenteral; Middle Aged; Penicillanic Acid; Pregnancy; Sulbactam | 1984 |
[Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Exudates and Transudates; Female; Genital Diseases, Female; Genitalia, Female; Humans; Injections, Intravenous; Middle Aged; Pelvis; Penicillanic Acid; Sulbactam | 1984 |
[Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Genitalia, Female; Humans; Injections, Intravenous; Middle Aged; Penicillanic Acid; Sulbactam | 1984 |
[Fundamental and clinical studies of sulbactam/cefoperazone in obstetrics and gynecology].
Topics: Adolescent; Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Injections, Intravenous; Middle Aged; Penicillanic Acid; Pregnancy; Sulbactam | 1984 |
[Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Injections, Intravenous; Middle Aged; Penicillanic Acid; Pregnancy; Sulbactam | 1984 |
[Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adolescent; Adult; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Infusions, Parenteral; Middle Aged; Penicillanic Acid; Pregnancy; Sulbactam | 1984 |
[Bacteriological, pharmacokinetic and clinical studies on sulbactam/cefoperazone in the pediatric field].
Topics: Adolescent; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Penicillanic Acid; Sulbactam | 1984 |
[Basic and clinical evaluation of sulbactam/cefoperazone in the field of pediatrics].
Topics: Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Penicillanic Acid; Sulbactam | 1984 |
[Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Genital Diseases, Female; Humans; Middle Aged; Penicillanic Acid; Sulbactam | 1984 |
Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Cefoperazone; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Synergism; Penicillanic Acid; Sulbactam | 1981 |
Bactericidal activity of cefoperazone with CP-45,899 against large inocula of beta-lactamase-producing Haemophilus influenzae.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Cephalosporins; Drug Synergism; Haemophilus influenzae; Penicillanic Acid; Sulbactam | 1981 |
Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production.
Topics: Anti-Bacterial Agents; Bacteroides; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Cell Membrane Permeability; Cephalosporins; Clavulanic Acids; Drug Synergism; Edetic Acid; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam | 1982 |
Pharmacokinetics of sulbactam in humans.
Topics: Adult; Ampicillin; Cefoperazone; Cephalosporins; Drug Combinations; Drug Interactions; Gas Chromatography-Mass Spectrometry; Humans; Kinetics; Male; Penicillanic Acid; Penicillin G; Sulbactam | 1983 |
[Cefoperazone, cefsulodin and ceftazidime--3 cephalosporins active against Pseudomonas in comparison with their monobactam analogs].
Topics: beta-Lactamase Inhibitors; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Humans; Monobactams; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam | 1983 |
Antibiotic pasting for foul putrefactive cancers.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Breast Neoplasms; Cefoperazone; Drug Combinations; Female; Humans; Infections; Rectal Neoplasms; Sulbactam; Tongue Neoplasms | 1995 |
[Antibiotic and anti-cancer pasting for putrefactive cancers].
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Cefoperazone; Cisplatin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Ointments; Piperacillin; Radiation Injuries; Radiotherapy; Rectal Neoplasms; Sulbactam; Suppuration; Ulcer | 1995 |
[Comparative in vitro activity of ampicillin, cefoperazone, their combinations with sulbactam and other antibiotics with respect to staphylococci and pneumococci].
Topics: Ampicillin; Cefoperazone; Drug Therapy, Combination; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Streptococcus pneumoniae; Sulbactam | 1995 |
[Comparative in vitro activity of ampicillin, cefoperazone and their combinations with sulbactam, as well as that of other antibiotics against anaerobic organisms].
Topics: Ampicillin; Bacteria, Anaerobic; Cefoperazone; Cefoxitin; Drug Combinations; Drug Resistance, Microbial; Imipenem; Metronidazole; Microbial Sensitivity Tests; Sulbactam | 1995 |
Treatment of late Lyme borreliosis with cefoperazone and sulbactam.
Topics: Adult; beta-Lactam Resistance; Borrelia burgdorferi Group; Cefoperazone; Drug Therapy, Combination; Humans; Immunoglobulin G; Lyme Disease; Male; Sulbactam | 1995 |
Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carrier Proteins; Cefoperazone; Female; Hexosyltransferases; Methicillin Resistance; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin G; Penicillin-Binding Proteins; Peptidyl Transferases; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Sulbactam | 1995 |
Steady-state pharmacokinetics of cefoperazone and sulbactam in patients with acute appendicitis.
Topics: Acute Disease; Adult; Appendectomy; Appendicitis; Cefoperazone; Female; Half-Life; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Sulbactam | 1994 |
First and second derivative spectrophotometric determination of cefoperazone and sulbactam in injections.
Topics: Anti-Infective Agents, Urinary; Cefoperazone; Dosage Forms; Drug Combinations; Hydrogen-Ion Concentration; Regression Analysis; Spectrophotometry, Ultraviolet; Sulbactam | 1994 |
[Reevaluation of current antimicrobials. Series 14: sulbactam sodium/cefoperazone sodium. Discussion].
Topics: Bacteria; Bacterial Infections; Cefoperazone; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Sulbactam | 1994 |
[Studies on the combined effect of fosfomycin with sulbactam/cefoperazone on methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa].
Topics: Cefoperazone; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Sulbactam | 1994 |
[Laboratory and clinical study on combined effects of fosfomycin plus sulbactam/cefoperazone for mixed infections of MRSA and Pseudomonas aeruginosa].
Topics: Aged; Cefoperazone; Drug Therapy, Combination; Fosfomycin; Humans; Male; Methicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulbactam | 1994 |
In-vitro antimicrobial studies with the combination of cefoperazone and sulbactam.
Topics: Ampicillin; Bacteria; Cefoperazone; Drug Therapy, Combination; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Sulbactam; Time Factors | 1993 |
[beta-lactamase activity in sputum of patients with community-acquired lower respiratory tract infections].
Topics: beta-Lactamases; Cefoperazone; Haemophilus influenzae; Humans; Piperacillin; Respiratory Tract Infections; Sputum; Streptococcus pneumoniae; Sulbactam | 1994 |
Therapy with cefoperazone plus sulbactam against disseminated infection due to cefoperazone-resistant Pseudomonas aeruginosa and Escherichia coli in granulocytopenic mice.
Topics: Agranulocytosis; Animals; beta-Lactamases; Cefoperazone; Colony Count, Microbial; Cyclophosphamide; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam | 1993 |
[Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Cefoperazone; Drug Evaluation; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Male; Middle Aged; Sulbactam | 1993 |
Efficacy of cefoperazone in combination with sulbactam in experimental Staphylococcus aureus endocarditis in rabbits.
Topics: Animals; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carrier Proteins; Cefoperazone; Drug Therapy, Combination; Endocarditis, Bacterial; Hexosyltransferases; Methicillin Resistance; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Sulbactam | 1993 |
[In vitro susceptibility to cefoperazone and sulbactam/cefoperazone combination of bacterial strains isolated from various patient materials].
Topics: Bacteria; beta-Lactamases; Cefoperazone; Drug Combinations; Humans; Microbial Sensitivity Tests; Sulbactam | 1993 |
Resistance to cefoperazone-sulbactam in Klebsiella pneumoniae: evidence for enhanced resistance resulting from the coexistence of two different resistance mechanisms.
Topics: Abscess; Animals; Bacterial Outer Membrane Proteins; beta-Lactamases; Cefoperazone; Drug Resistance, Microbial; Drug Therapy, Combination; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Porins; Rats; Rats, Sprague-Dawley; Species Specificity; Sulbactam | 1993 |
[A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Cefoperazone; Drug Combinations; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Immunocompromised Host; Leukocyte Count; Male; Middle Aged; Neutrophils; Sulbactam | 1993 |
[A case report of pyomyositis--early diagnosis and follow-up by MRI].
Topics: Adult; Cefoperazone; Drug Therapy, Combination; Female; Fosfomycin; Humans; Magnetic Resonance Imaging; Muscle, Skeletal; Myositis; Sulbactam; Tomography, X-Ray Computed | 1995 |
[A trial of using sulperazone (cefoperazone/sulbactam) in the combined treatment of patients with a burn infection].
Topics: Adolescent; Adult; Anti-Infective Agents; Bacterial Infections; Burns; Cefoperazone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Sulbactam; Time Factors | 1995 |
[In vitro antibacterial activity of sulperazone on multi-resistant strains of bacteria from burn wounds].
Topics: Anti-Bacterial Agents; Burns; Cefoperazone; Cephalosporins; Drug Combinations; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis; Sulbactam | 1995 |
[In vitro antibacterial activity of cefoperazone-sulbactam].
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteroides fragilis; Cefoperazone; Cephalosporins; Drug Combinations; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sulbactam | 1995 |
[In vitro activities of sulopenem, a new parenteral penem, against anaerobes].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactamases; beta-Lactams; Cecum; Cefoperazone; Ceftizoxime; Cephalosporins; Clostridioides difficile; Drug Stability; Drug Therapy, Combination; Imipenem; Lactams; Male; Mice; Mice, Inbred ICR; Sulbactam; Thienamycins | 1996 |
[Efficacy of sulbactam/cefoperazone in respiratory tract infections in elderly patients with underlying respiratory diseases].
Topics: Aged; Aged, 80 and over; Asthma; Cefoperazone; Drug Combinations; Female; Humans; Lung Neoplasms; Male; Pulmonary Emphysema; Pulmonary Fibrosis; Respiratory Tract Diseases; Respiratory Tract Infections; Sulbactam; Tuberculosis, Pulmonary | 1996 |
Molecular aspects of high-level resistance to sulbactam-cefoperazone in Klebsiella oxytoca clinical isolates.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacteriophages; Base Sequence; beta-Lactamases; Blotting, Southern; Cefoperazone; Cephalosporins; Cloning, Molecular; Culture Media; Databases, Factual; Drug Therapy, Combination; Indicators and Reagents; Klebsiella; Klebsiella Infections; Molecular Sequence Data; Molecular Weight; Nucleic Acid Hybridization; Plasmids; Sulbactam | 1996 |
In-vitro activity of cefoperazone-sulbactam combination against cefoperazone resistant clinical isolates in a Malaysian general hospital.
Topics: Cefoperazone; Cephalosporin Resistance; Cross Infection; Drug Combinations; Gram-Negative Bacterial Infections; Hospitals, General; Malaysia; Sulbactam | 1995 |
Comparative in-vitro activity of cefoperazone/sulbactam and 11 other agents against multidrug resistant Bacteroides fragilis group species.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporin Resistance; Drug Resistance, Multiple; Microbial Sensitivity Tests; Sulbactam | 1996 |
Incidence of diarrhea with antibiotics and the increase of clostridia in rabbits.
Topics: Animals; Anti-Bacterial Agents; Cefoperazone; Clostridioides difficile; Clostridium; Clostridium Infections; Diarrhea; Drug Therapy, Combination; Incidence; Rabbits; Sulbactam | 1996 |
Cases of Lyme borreliosis resistant to conventional treatment: improved symptoms with cephalosporin plus specific beta-lactamase inhibition.
Topics: beta-Lactamase Inhibitors; Cefoperazone; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Infusions, Intravenous; Lyme Disease; Male; Middle Aged; Sulbactam | 1995 |
Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Topics: Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Retrospective Studies; Sulbactam; Tazobactam; Ticarcillin; Urinary Tract; Urinary Tract Infections | 1997 |
In vitro activity of cefoperazone-sulbactam: Singapore experience.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefoperazone; Cephalosporin Resistance; Cephalosporins; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Singapore; Sulbactam | 1996 |
Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporinase; Cephalosporins; Cohort Studies; Colombia; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Reproducibility of Results; Staphylococcus; Sulbactam | 1997 |
[Evaluation of antibacterial activities of various antibiotics against glucose non-fermentative gram-negative rods other than Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Gram-Negative Aerobic Rods and Cocci; Humans; Imipenem; Minocycline; Penicillin Resistance; Penicillins; Piperacillin; Sulbactam; Thienamycins | 1998 |
Comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Fever; Humans; Imipenem; Sulbactam; Thienamycins | 1999 |
[Antibacterial activity in vitro and clinical use of sulperazon].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bronchitis; Cefoperazone; Drug Combinations; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sulbactam | 1997 |
Sulbactam-cefoperazone polyhydroxybutyrate-co-hydroxyvalerate (PHBV) local antibiotic delivery system: in vivo effectiveness and biocompatibility in the treatment of implant-related experimental osteomyelitis.
Topics: Animals; Biocompatible Materials; Biodegradation, Environmental; Cefoperazone; Drug Carriers; Drug Implants; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Osteomyelitis; Polyesters; Rabbits; Radiography; Staphylococcal Infections; Sulbactam; Tibia | 1999 |
[Study on the beta-lactamases of the Escherichia coli HX88108 resistant to ceforperazon].
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefoperazone; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli; Hydrolysis; Sulbactam | 1998 |
[Use of sulperazone in acute surgical conditions].
Topics: Abdomen; Acute Disease; Anti-Infective Agents; Bacterial Infections; Cefoperazone; Drug Combinations; Female; Humans; Male; Middle Aged; Preoperative Care; Sulbactam | 1999 |
In-vitro susceptibility of Burkholderia pseudomallei to cefoperazone-sulbactam combination.
Topics: Burkholderia pseudomallei; Cefoperazone; Drug Therapy, Combination; Microbial Sensitivity Tests; Sulbactam | 1997 |
In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis.
Topics: Absorbable Implants; Ampicillin; Animals; Cefoperazone; Drug Carriers; Drug Combinations; Humans; Hydroxybutyrates; Osteomyelitis; Polyesters; Prostheses and Implants; Prosthesis Implantation; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Tibia | 2001 |
Effect of sulbactam on anti-pseudomonal activity of beta-lactam antibiotics in cells producing various levels of the MexAB-OprM efflux pump and beta-lactamase.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamase Inhibitors; Carrier Proteins; Cefoperazone; Cefsulodin; Drug Synergism; Enzyme Inhibitors; Membrane Transport Proteins; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Sulbactam | 2000 |
[Clinical analysis of neutropenic fever associated with hematological disorders].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Infective Agents, Urinary; Cefoperazone; Drug Combinations; Drug Therapy, Combination; Female; Fever; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Serum Albumin; Sulbactam | 2001 |
An anaphylactic reaction possibly associated with an intraoperative coronary artery spasm during general anesthesia.
Topics: Aged; Anaphylaxis; Anesthesia, General; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Coronary Angiography; Coronary Vasospasm; Electrocardiography; Gallstones; Humans; Intraoperative Complications; Male; Sulbactam | 2001 |
Biodegradable polyhydroxyalkanoate implants for osteomyelitis therapy: in vitro antibiotic release.
Topics: Ampicillin; Anti-Bacterial Agents; Biocompatible Materials; Cefoperazone; Drug Combinations; Drug Implants; Humans; Hydroxybutyrates; In Vitro Techniques; Materials Testing; Microscopy, Electron, Scanning; Osteomyelitis; Polyesters; Sulbactam | 2001 |
The penetration of cefoperazone and sulbactam into the lumbar intervertebral discs.
Topics: Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Therapy, Combination; Humans; Intervertebral Disc; Lumbar Vertebrae; Sulbactam | 2001 |
In vitro activity of sulperazon against recent isolates of ceftazidime-resistant bacteria.
Topics: Acinetobacter; Bacteria; Cefoperazone; Ceftazidime; Drug Combinations; Drug Resistance, Microbial; Humans; In Vitro Techniques; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sulbactam | 2001 |
The role of cefoperazone-sulbactam for treatment of severe melioidosis.
Topics: Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Therapy, Combination; Humans; Melioidosis; Sulbactam | 2002 |
Effect of cefaperazone/sulbactam and ampicillin/sulbactam on the in vitro activity of human erythrocyte glucose-6-phosphate dehydrogenase.
Topics: Ammonium Sulfate; Ampicillin; Blood Proteins; Cefoperazone; Chromatography, Affinity; Drug Therapy, Combination; Electrophoresis, Polyacrylamide Gel; Erythrocytes; Glucosephosphate Dehydrogenase; Hemolysis; Humans; In Vitro Techniques; Kinetics; Sulbactam | 2001 |
Pharmacokinetics of cefoperazone and sulbactam in liver transplant patients.
Topics: Adult; Anti-Bacterial Agents; Bile; Cefoperazone; Humans; Kidney; Liver Transplantation; Metabolic Clearance Rate; Sulbactam | 2002 |
Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroidaceae Infections; beta-Lactams; Cefepime; Cefmetazole; Cefoperazone; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Fusobacterium; Fusobacterium Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Mouth Diseases; Penicillin G; Penicillins; Peptostreptococcus; Porphyromonas gingivalis; Prevotella; Streptococcal Infections; Streptococcus; Sulbactam | 2002 |
[Simultaneous determination of sulbactam sodium and cefoperazone sodium in sulperazon by high performance liquid chromatography].
Topics: Anti-Infective Agents, Urinary; Cefoperazone; Chromatography, High Pressure Liquid; Drug Combinations; Sulbactam | 2000 |
[Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Intensive Care Units; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Sulbactam | 2003 |
[Sulperazone in the treatment of severe infections in patients with cancer].
Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Combinations; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Neoplasms; Pneumonia, Bacterial; Sulbactam; Surgical Wound Infection; Urinary Tract Infections | 2003 |
The status of drug resistance and ampC gene expression in Enterobacter cloacae.
Topics: beta-Lactamases; Cefoperazone; Drug Resistance, Bacterial; Enterobacter cloacae; Gene Expression; Genes, Bacterial; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sulbactam | 2003 |
The susceptibility of non-fermentative Gram-negative bacilli to cefperazone and sulbactam compared with other antibacterial agents.
Topics: Anti-Bacterial Agents; Cefoperazone; Gram-Negative Bacteria; Microbial Sensitivity Tests; Sulbactam | 2003 |
Preoperative antimicrobial administration for prevention of postoperative infection in patients with laparoscopic cholecystectomy.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; Bile; Cefoperazone; Cholecystectomy, Laparoscopic; Female; Gallbladder; Humans; Infection Control; Male; Middle Aged; Postoperative Complications; Preoperative Care; Sulbactam; Surgical Wound Infection | 2003 |
[Surveillance of susceptibility of clinical isolates to cefmetazole between 2000 and 2002].
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefazolin; Cefmetazole; Cefoperazone; Cefotiam; Drug Resistance, Bacterial; Humans; Japan; Sulbactam; Time Factors | 2003 |
In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
Topics: Acinetobacter baumannii; Ampicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serratia marcescens; Sulbactam | 2004 |
[Survey of the utilization and adverse effects of antibacterial drugs in patients admitted for respiratory diseases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bronchitis; Cefoperazone; Female; Hospitalization; Humans; Lung Neoplasms; Male; Middle Aged; Pneumonia; Sulbactam | 2005 |
Cefoperazone or cefoperazone-sulbactam as perioperative antibiotic prophylaxis in transurethral surgery.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefoperazone; Humans; Intraoperative Care; Sulbactam; Surgical Wound Infection; Urethra; Urologic Surgical Procedures | 1989 |
[Clinical experience with the treatment of severe nosocomial infections by inhibitor-protected 3rd generation cephalosporin cefoperazone/sulbactam].
Topics: Adult; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Cross Infection; Drug Combinations; Gram-Negative Bacteria; Humans; Infant; Male; Middle Aged; Postoperative Complications; Sulbactam | 2005 |
Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acids; Cross Infection; Gram-Negative Bacteria; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Ticarcillin | 2005 |
Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cefoperazone; Cilastatin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Protease Inhibitors; Sulbactam | 2006 |
[The combination effects of antibacterial agents against clinical isolated multiple-drug resistant Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Meropenem; Microbial Sensitivity Tests; Oxazines; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Thienamycins | 2006 |
Cefoperazone / sulbactam induced hyponatremia.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Drug Therapy, Combination; Female; Humans; Hyponatremia; Microbial Sensitivity Tests; Sulbactam | 2006 |
[Three-year experience with the use of cefoperazone/sulbactam (sulperazone) in the treatment of hospital-acquired infections in an oncologic hospital].
Topics: Anti-Infective Agents; Candida; Cefoperazone; Cross Infection; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Oncology Service, Hospital; Sulbactam | 2006 |
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data.
Topics: Bacteria; Cefoperazone; Drug Combinations; Humans; Intensive Care Units; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam | 2007 |
Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
Topics: Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Humans; Male; Methicillin Resistance; Middle Aged; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Sulbactam | 2007 |
Pacemaker pocket infection associated with septicemia caused by Pseudomonas aeruginosa.
Topics: Adult; Anti-Bacterial Agents; Cardiac Surgical Procedures; Cardiomyopathy, Hypertrophic; Cefoperazone; Drug Therapy, Combination; Female; Gentamicins; Humans; Metronidazole; Pacemaker, Artificial; Pseudomonas Infections; Sepsis; Sulbactam; Surgical Wound Infection | 2008 |
Simultaneous determination of ampicillin, cefoperazone, and sulbactam in pharmaceutical formulations by HPLC with beta-cyclodextrin stationary phase.
Topics: Ampicillin; beta-Cyclodextrins; Cefoperazone; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Chromatography; Chromatography, High Pressure Liquid; Drug Combinations; Glucose; Methanol; Models, Chemical; Reproducibility of Results; Sulbactam; Temperature | 2007 |
Giant subcutaneous abscess after percutaneous endoscopic gastrostomy.
Topics: Abscess; Aged; Cefoperazone; Connective Tissue Diseases; Drainage; Drug Therapy, Combination; Enterococcus faecium; Gastrostomy; Gram-Positive Bacterial Infections; Humans; Male; Subcutaneous Tissue; Sulbactam | 2007 |
Pacemaker generator pocket infection due to Burkholderia cepacia.
Topics: Aged; Anti-Bacterial Agents; Burkholderia cepacia; Burkholderia Infections; Cefoperazone; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Ofloxacin; Pacemaker, Artificial; Prosthesis-Related Infections; Sulbactam | 2007 |
[Resistance epidemiology of gramnegative nonfermenting pathogens of nosocomial infections in intensive care units and surgical departments].
Topics: Acinetobacter baumannii; Adolescent; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoperazone; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Genes, Bacterial; Gram-Negative Bacterial Infections; Humans; Infant; Intensive Care Units; Microbial Sensitivity Tests; Molecular Epidemiology; Moscow; Pseudomonas aeruginosa; Sulbactam; Surgery Department, Hospital | 2006 |
A fatal case of suspected anaphylaxis with cefoperazone and sulbactam: LC-MS analysis.
Topics: Adult; Anaphylaxis; Anti-Bacterial Agents; Cefoperazone; Chromatography, Liquid; Forensic Toxicology; Humans; Infusions, Intravenous; Male; Mass Spectrometry; Sulbactam | 2008 |
[Assessment of the susceptibility of the gram-negative rods isolated from hospitalized patients to cefoperazone/sulbactam].
Topics: Anti-Infective Agents; beta-Lactamases; Cefoperazone; Cephalosporin Resistance; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Gram-Negative Aerobic Rods and Cocci; Humans; Sulbactam | 2008 |
Synergy of gatifloxacin with cefoperazone and cefoperazone-sulbactam against resistant strains of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cefoperazone; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Gatifloxacin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam | 2008 |
[Regression of mucosa-associated lymphoid tissue lymphoma of the bladder after antibiotic therapy: a case report].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Clarithromycin; Female; Helicobacter Infections; Humans; Lymphoma, B-Cell, Marginal Zone; Sulbactam; Urinary Bladder Neoplasms | 2008 |
In vitro activities of piperacillin or cefoperazone alone and in combination with beta-lactamase inhibitors against gram-negative bacilli.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cefoperazone; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam | 2009 |
Emergence of resistance to third-generation cephalosporin in Shigella--a case report.
Topics: Anti-Bacterial Agents; Cefoperazone; Drug Combinations; Drug Resistance, Multiple, Bacterial; Dysentery, Bacillary; Feces; Humans; India; Infant; Male; Microbial Sensitivity Tests; Shigella flexneri; Sulbactam | 2010 |
A case of immune hemolytic anemia induced by ceftizoxime and cefobactam (sulbactam/cefoperazone).
Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Cefoperazone; Ceftizoxime; Erythrocytes; Female; Humans; Middle Aged; Sulbactam | 2009 |
Liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of cefoperazone and sulbactam in plasma and its application to a pharmacokinetic study.
Topics: Anti-Bacterial Agents; Cefoperazone; Chromatography, High Pressure Liquid; Drug Combinations; Humans; Spectrometry, Mass, Electrospray Ionization; Sulbactam; Tandem Mass Spectrometry | 2010 |
Novel insights into the mode of inhibition of class A SHV-1 beta-lactamases revealed by boronic acid transition state inhibitors.
Topics: beta-Lactamase Inhibitors; Boronic Acids; Cefoperazone; Ceftazidime; Clavulanic Acid; Enzyme Inhibitors; Klebsiella pneumoniae; Magnetic Resonance Spectroscopy; Penicillanic Acid; Sulbactam; Tazobactam | 2011 |
Japanese spotted fever with acute hepatic failure: was it associated with Epstein-Barr virus?
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; Cholecystitis, Acute; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Liver Failure, Acute; Minocycline; Polymerase Chain Reaction; Rickettsia; Rickettsia Infections; Sulbactam | 2010 |
Endovascular repair and pharmacotherapy of an inflammatory abdominal aortic aneurysm complicated by primary aortoduodenal fistula.
Topics: Aged; Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Aortic Diseases; Aortography; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Cefoperazone; Drug Combinations; Duodenal Diseases; Endoscopy, Gastrointestinal; Endovascular Procedures; Gastrointestinal Agents; Humans; Intestinal Fistula; Male; Octreotide; Stents; Sulbactam; Tomography, X-Ray Computed; Treatment Outcome; Vascular Fistula | 2011 |
Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units.
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Czech Republic; Drug Resistance, Multiple, Bacterial; Gentamicins; Intensive Care Units; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam | 2011 |
Use of cefoperazone/sulbactam in neonates.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Sulbactam | 2012 |
Frequency and antibiogram of multi-drug resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cefoperazone; Colistin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam | 2011 |
[Assessment of efficacies of imipenem, cefoperazone-sulbactam and cefepime in rats with experimental thigh abscess model with multidrug resistant and susceptible Acinetobacter baumannii strains].
Topics: Abscess; Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Cefepime; Cefoperazone; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Imipenem; Random Allocation; Rats; Rats, Wistar; Serum Bactericidal Test; Soft Tissue Infections; Sulbactam; Thigh | 2011 |
Augmentation in zone of inhibition of cefoperazone/cefoperazone+ sulbactum compares well with the clinical laboratory standard institute standard extended spectrum beta-lactamase detection method as well as the polymerase chain reaction method.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefoperazone; Cefotaxime; Ceftazidime; Clavulanic Acid; Drug Combinations; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sulbactam | 2011 |
Activity of beta-lactam beta-lactamase inhibitor combinations against extended spectrum Beta-lactamase producing Enterobacteriaceae in urinary isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acids; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sensitivity and Specificity; Sulbactam; Urinary Tract Infections | 2012 |
[A case of ventilator-associated pneumonia due to Pantoea agglomerans].
Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Therapy, Combination; Enterobacteriaceae Infections; Heart Arrest; Humans; Kidney Failure, Chronic; Male; Middle Aged; Ofloxacin; Opportunistic Infections; Pantoea; Pneumonia, Ventilator-Associated; Respiration, Artificial; Sulbactam | 2012 |
[Comparative estimation of the application efficacy for ceftriaxon and Hepacef combi preparations in the abdominal infection treatment].
Topics: Abdominal Cavity; Adult; Anti-Bacterial Agents; Blood Cell Count; Cefoperazone; Ceftriaxone; Drug Administration Schedule; Drug Combinations; Drug Synergism; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intraabdominal Infections; Male; Middle Aged; Postoperative Complications; Sulbactam; Treatment Outcome; Ukraine | 2012 |
[In vitro resistance development in Acinetobacter baumannii to sulbactam and cefoperazone].
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Cefoperazone; Microbial Sensitivity Tests; Species Specificity; Sulbactam | 2012 |
In vitro activity of minocycline alone and in combination with cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cefoperazone; Drug Synergism; Drug Therapy, Combination; Humans; Intensive Care Units; Microbial Sensitivity Tests; Minocycline; Sulbactam | 2012 |
A fatal mongoose bite.
Topics: Animals; Anti-Infective Agents; Bites and Stings; Cefoperazone; Drug Therapy, Combination; Fatal Outcome; Female; Heart Arrest; Herpestidae; Humans; India; Injections; Leg Injuries; Metronidazole; Middle Aged; Skin; Streptococcal Infections; Sulbactam; Wound Infection | 2012 |
[Cefoperazone-sulbactam plus minocycline in the treatment of extensively drug resistant Acinetobacter infections].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Cefoperazone; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Minocycline; Prospective Studies; Sulbactam | 2012 |
[Protective effects of snake venom antimicrobial peptide OH-CATH on E. coli induced rabbit urinary tract infection models].
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Host-Pathogen Interactions; Male; Microscopy, Electron, Transmission; Molecular Sequence Data; Peptides; Rabbits; Snake Venoms; Sulbactam; Urinary Bladder; Urinary Tract Infections | 2013 |
In vitro activity of sulbactam in combination with imipenem, meropenem, panipenem or cefoperazone against clinical isolates of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactams; Cefoperazone; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 2013 |
In vitro activity of cefoperazone-sulbactam combination against gram negative bacilli.
Topics: Anti-Bacterial Agents; Cefoperazone; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Sulbactam | 2012 |
[Application of gepacef comby for an acute surgical diseases of organs of the hepatopancreatobiliary zone].
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Cefoperazone; Cholecystitis; Drug Combinations; Female; Humans; Intraabdominal Infections; Liver Abscess; Male; Middle Aged; Pancreatitis, Acute Necrotizing; Sulbactam; Treatment Outcome; Young Adult | 2013 |
Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporin Resistance; Disk Diffusion Antimicrobial Tests; Drug Combinations; Humans; India; Penicillanic Acid; Respiratory Tract Infections; Sulbactam; Tazobactam; Urinary Tract Infections | 2012 |
Antibiotic resistance and OXA-type carbapenemases-encoding genes in airborne Acinetobacter baumannii isolated from burn wards.
Topics: Acinetobacter baumannii; Air Microbiology; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burn Units; Carbapenems; Cefoperazone; Ceftriaxone; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Repetitive Sequences, Nucleic Acid; Sulbactam | 2014 |
Interaction between caspofungin or voriconazole and cefoperazone-sulbactam or piperacillin-tazobactam by in vitro and in vivo methods.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Candida albicans; Candidiasis; Caspofungin; Cefoperazone; Drug Interactions; Echinocandins; Female; Lipopeptides; Mice; Mice, Inbred BALB C; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyrimidines; Sulbactam; Triazoles; Voriconazole | 2014 |
In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Cefoperazone; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Tigecycline | 2013 |
Preparation of ZnS:Ni/ZnS quantum dots with core/shell structure and application for detecting cefoperazone-sulbactam.
Topics: Buffers; Calibration; Cefoperazone; Hydrogen-Ion Concentration; Nickel; Quantum Dots; Spectrometry, Fluorescence; Spectrophotometry, Atomic; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Sulbactam; Sulfides; Thermogravimetry; X-Ray Diffraction; Zinc Compounds | 2014 |
Piperacillin/tazobactam vs. cefoperazone/sulbactam in adult low-risk febrile neutropenia cases.
Topics: Anti-Bacterial Agents; Cefoperazone; Drug Combinations; Febrile Neutropenia; Female; Humans; Male; Middle Aged; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Sulbactam; Treatment Outcome | 2014 |
UV spectrophotometric simultaneous determination of cefoperazone and sulbactam in pharmaceutical formulations by derivative, Fourier and wavelet transforms.
Topics: Analysis of Variance; Calibration; Cefoperazone; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Fourier Analysis; Reproducibility of Results; Spectrophotometry, Ultraviolet; Sulbactam; Wavelet Analysis | 2014 |
A combination regimen of meropenem, cefoperazone-sulbactam and minocycline for extensive burns with pan-drug resistant Acinetobacter baumannii infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Burns; Cefoperazone; Humans; Meropenem; Middle Aged; Minocycline; Retrospective Studies; Sulbactam; Thienamycins; Young Adult | 2014 |
A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam.
Topics: Acinetobacter baumannii; Aged; Aged, 80 and over; Anti-Bacterial Agents; C-Reactive Protein; Carbapenems; Cefoperazone; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Humans; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Thienamycins | 2014 |
[Pattern dynamics of bacteriemia and sepsis pathogens in ICU patients of emergency service].
Topics: Acetamides; Acinetobacter; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Candida; Candidiasis; Carbapenems; Cefoperazone; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Klebsiella pneumoniae; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Sulbactam; Vancomycin | 2013 |
First report of Nocardia farcinica bursitis in a patient with diabetes mellitus.
Topics: Aged; Anti-Bacterial Agents; Bursitis; Cefoperazone; Diabetes Mellitus, Type 2; Humans; Male; Nocardia; Polymerase Chain Reaction; RNA, Ribosomal, 16S; Sequence Analysis, RNA; Sulbactam | 2014 |
[Preliminary analysis on the treatment of ventilator-associated pneumonia caused by pandrug-resistant Acinetobacter baumannii].
Topics: Acinetobacter baumannii; Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Minocycline; Pneumonia, Ventilator-Associated; Retrospective Studies; Sulbactam; Treatment Outcome | 2014 |
[In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefoperazone; Cross Infection; Drug Combinations; Drug Synergism; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 2014 |
Perforation of a duodenal ulcer into a non-parasitic liver cyst: a rare case of a penetrate hole blockaded with conservative medical management.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; Cysts; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Digestive System; Female; Humans; Liver Diseases; Omeprazole; Peptic Ulcer Perforation; Proton Pump Inhibitors; Sulbactam; Tomography, X-Ray Computed | 2014 |
[Treatment approaches for bronchopulmonary infection in myasthenia gravis patients].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bronchopneumonia; Cefoperazone; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Myasthenia Gravis; Pneumonia, Bacterial; Sulbactam; Treatment Outcome | 2014 |
In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cefoperazone; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Sulbactam; Tigecycline | 2015 |
[Experimental study on concentrations and pharmacokinetics of antibiotics in bile and evaluation of their microbicidal potential].
Topics: Animals; Anti-Bacterial Agents; Bile; Cefoperazone; Drug Combinations; Meropenem; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rabbits; Random Allocation; Sulbactam; Thienamycins | 2014 |
A Non-inferiority Pilot Study Comparing the Clinical Efficacy and Safety of Generic Wide-spectrum Antibiotic Use in Septic Oncology Patients.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drugs, Generic; Female; Humans; Imipenem; Male; Middle Aged; Oncology Service, Hospital; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Sepsis; Sulbactam; Treatment Outcome | 2015 |
Successful treatment of multifoci nocardial brain abscesses: a case report and literature review.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Brain Abscess; Cefoperazone; Drug Therapy, Combination; Humans; Immunocompromised Host; Linezolid; Male; Nocardia Infections; Opportunistic Infections; Oxazolidinones; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2015 |
Modeling and forecasting Acinetobacter baumannii resistance to set appropriate use of cefoperazone-sulbactam: Results from trend analysis of antimicrobial consumption and development of resistance in a tertiary care hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cefoperazone; Drug Resistance, Bacterial; Drug Utilization; Humans; Models, Statistical; Retrospective Studies; Sulbactam; Tertiary Care Centers | 2015 |
Wohlfahrtiimonas chitiniclastica-associated osteomyelitis: a rare case report.
Topics: Administration, Intravenous; Adult; Cefoperazone; Communicable Diseases, Emerging; Diabetes Complications; DNA, Bacterial; Gammaproteobacteria; Gram-Negative Bacterial Infections; Humans; India; Male; Molecular Sequence Data; Osteomyelitis; Phylogeny; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Sulbactam; Tertiary Care Centers; Wounds and Injuries | 2015 |
Comparison of commonly used antimicrobial susceptibility testing methods for evaluating susceptibilities of clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli to cefoperazone-sulbactam.
Topics: Anti-Bacterial Agents; Automation, Laboratory; beta-Lactamase Inhibitors; Cefoperazone; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Sulbactam; Taiwan | 2017 |
[Analysis of clinical manifestations and risk factors of mortality in Acinetobacter baumannii bloodstream infection].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; APACHE; Bacteremia; Cefoperazone; Humans; Retrospective Studies; Risk Factors; Shock, Septic; Sulbactam | 2016 |
Effectiveness and Safety of Generic Formulation of Cefoperazone/Sulbactam (Bacticep®) in Treatment of Infections at Siriraj Hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Databases, Factual; Drug Combinations; Drugs, Generic; Female; Hospitals; Humans; Male; Middle Aged; Retrospective Studies; Safety; Sulbactam; Treatment Outcome; Young Adult | 2016 |
The First Case Report of Acute Cholangitis and Bacteremia Due to Neisseria subflava.
Topics: Acute Disease; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cefoperazone; Cholangiocarcinoma; Cholangitis; Diagnosis, Differential; Drainage; Drug Therapy, Combination; Humans; Male; Neisseria; Pancreaticoduodenectomy; Sulbactam; Tomography, X-Ray Computed | 2017 |
A case of pyometrocolpos with Bifidobacterium species.
Topics: Anti-Bacterial Agents; Bifidobacteriales Infections; Bifidobacterium; Cefoperazone; Child, Preschool; Drainage; Female; Humans; Metronidazole; Pyometra; Sulbactam | 2017 |
Comparison of the efficacies of three empirically-selected antibiotics for treating Acinetobacter baumannii pulmonary infection: experience from a teaching hospital in China
.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Cefoperazone; China; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Hospitals, Teaching; Humans; Male; Middle Aged; Minocycline; Respiratory Tract Infections; Retrospective Studies; Sputum; Sulbactam; Tigecycline; Time Factors; Treatment Outcome | 2017 |
Trends in Drug Resistance of
Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Cefepime; Cefoperazone; Ceftazidime; Cephalosporins; China; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2017 |
Antibiotics susceptibility patterns of uropathogenic E. coli with special reference to fluoroquinolones in different age and gender groups.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Imipenem; Infant; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Sulbactam; Tazobactam; Urinary Tract Infections; Young Adult | 2017 |
Effects of specific egg yolk immunoglobulin on pan-drug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Disease; Animals; Anti-Bacterial Agents; Cefoperazone; Dexamethasone; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Egg Yolk; Enzyme-Linked Immunosorbent Assay; Immunoglobulins; Injections, Intraperitoneal; Interleukin-1beta; Male; Mice; Mice, Inbred BALB C; Pneumonia, Bacterial; Sulbactam; Tumor Necrosis Factor-alpha | 2017 |
Determination of cefoperazone and sulbactam in serum by HPLC-MS/MS: An adapted method for therapeutic drug monitoring in children.
Topics: Cefoperazone; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Humans; Limit of Detection; Linear Models; Reproducibility of Results; Sulbactam; Tandem Mass Spectrometry | 2018 |
Genotypic variations between wild-type and small colony variant of Staphylococcus aureus in prosthetic valve infectious endocarditis: a comparative genomic and transcriptomic analysis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; Cefoperazone; Endocarditis; Female; Gene Expression Profiling; Genome, Bacterial; Genotype; Heart Valve Prosthesis; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Polymorphism, Single Nucleotide; Staphylococcal Infections; Sulbactam; Transcriptome; Vancomycin; Virulence | 2018 |
Molecular Epidemiology and Mechanism of Sulbactam Resistance in Acinetobacter baumannii Isolates with Diverse Genetic Backgrounds in China.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Cefoperazone; China; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Reverse Transcriptase Polymerase Chain Reaction; Sulbactam | 2018 |
Amikacin and cefoperazone/sulbactam alone or in combination against carbapenem-resistant Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefoperazone; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Luminescent Measurements; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam | 2018 |
Comparison of empirical therapy with cefoperazone/sulbactam or a carbapenem for bloodstream infections due to ESBL-producing Enterobacteriaceae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Case-Control Studies; Cefoperazone; China; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam | 2018 |
Multidrug-resistance Acinetobacter baumannii pneumonia in a rheumatoid arthritis patient receiving tumor necrosis factor inhibitor: A case report.
Topics: Acinetobacter baumannii; Aged; Anti-Bacterial Agents; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Cefoperazone; Drug Resistance, Multiple; Female; Humans; Pneumonia; Radiography; Sulbactam; Tomography, X-Ray Computed; Treatment Outcome; Tumor Necrosis Factor-alpha | 2018 |
AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefoperazone; Cefoxitin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Pakistan; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2018 |
Molecular epidemiology and antibiotic resistance of Burkholderia pseudomallei isolates from Hainan, China: A STROBE compliant observational study.
Topics: Anti-Bacterial Agents; Burkholderia pseudomallei; Cefoperazone; Ceftazidime; China; Cluster Analysis; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Melioidosis; Prevalence; Retrospective Studies; Sulbactam | 2019 |
Dual-channel Microchip Electrophoresis with Amperometric Detection System for Rapid Analysis of Cefoperazone and Sulbactam.
Topics: Analytic Sample Preparation Methods; Buffers; Cefoperazone; Electrochemistry; Electrophoresis, Microchip; Humans; Hydrogen-Ion Concentration; Sulbactam; Time Factors | 2019 |
Pharmacokinetics of cefoperazone/sulbactam in plasma and cerebrospinal fluid in patients with intraventricular hemorrhage after external ventricular drains.
Topics: Anti-Bacterial Agents; Cefoperazone; Cerebral Intraventricular Hemorrhage; Drainage; Drug Combinations; Humans; Prospective Studies; Sulbactam | 2020 |
Antimicrobial activity of cefoperazone-sulbactam tested against Gram-Negative organisms from Europe, Asia-Pacific, and Latin America.
Topics: Acinetobacter; Anti-Bacterial Agents; Asia; Cefoperazone; Europe; Gammaproteobacteria; Gram-Negative Bacteria; Humans; Latin America; Pseudomonas aeruginosa; Sulbactam | 2020 |
Septic shock caused by Rhizobium radiobacter in an elderly woman: A case report.
Topics: Aged, 80 and over; Agrobacterium tumefaciens; Anti-Bacterial Agents; Cefoperazone; Disease Progression; Drug Therapy, Combination; Female; Humans; Levofloxacin; Shock, Septic; Sulbactam | 2019 |
In vitro interactions of ambroxol hydrochloride or amlodipine in combination with antibacterial agents against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ambroxol; Amlodipine; Anti-Bacterial Agents; Carbapenems; Cefoperazone; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 2020 |
Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Blood Coagulation Disorders; Blood Platelets; Cefoperazone; Ceftazidime; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Prothrombin Time; Sulbactam; Tazobactam; Young Adult | 2020 |
Be Careful with Adverse Events Caused by Cefoperazone-Sulbactam.
Topics: Anti-Bacterial Agents; Cefepime; Cefoperazone; Healthcare-Associated Pneumonia; Humans; Sulbactam | 2020 |
Reply to Zhou and Wu, "Be Careful with Adverse Events Caused by Cefoperazone-Sulbactam".
Topics: Anti-Bacterial Agents; Cefepime; Cefoperazone; Healthcare-Associated Pneumonia; Humans; Sulbactam | 2020 |
Determination of Total and Unbound Meropenem, Imipenem/Cilastatin, and Cefoperazone/Sulbactam in Human Plasma: Application for Therapeutic Drug Monitoring in Critically Ill Patients.
Topics: Cefoperazone; Chromatography, High Pressure Liquid; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Illness; Drug Monitoring; Humans; Imipenem; Meropenem; Plasma; Sulbactam; Tandem Mass Spectrometry | 2020 |
The effect of cefoperazone sulbactam and piperacillin tazobactam on mortality in Gram-negative nosocomial infections.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sulbactam | 2020 |
Treatment efficacy of tigecycline in comparison to cefoperazone/ sulbactam alone or in combination therapy for carbapenenm-resistant Acinetobacter baumannii infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pentostatin; Retrospective Studies; Sulbactam; Tigecycline | 2020 |
Case report: Mycobacterium monacense isolated from the blood culture of a patient with pulmonary infection.
Topics: Adult; Blood Culture; Cefoperazone; China; DNA, Ribosomal; Humans; Linezolid; Male; Mycobacterium; Mycobacterium Infections, Nontuberculous; Pneumonia, Bacterial; Sulbactam; Voriconazole | 2020 |
Campylobacter upsaliensis isolated from a giant hepatic cyst.
Topics: Aged; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter upsaliensis; Catheters; Cefoperazone; Cysts; DNA, Bacterial; Drug Therapy, Combination; Humans; Liver; Liver Abscess; Male; Multilocus Sequence Typing; Paracentesis; Sulbactam; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients.
Topics: Adult; Afibrinogenemia; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Blood Coagulation Tests; Case-Control Studies; Cefoperazone; Critical Illness; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Sulbactam; Tigecycline | 2020 |
Comment on: Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections.
Topics: Anti-Bacterial Agents; Cefepime; Cefoperazone; Sulbactam | 2020 |
Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections-authors' response.
Topics: Anti-Bacterial Agents; Cefepime; Cefoperazone; Sulbactam | 2020 |
Ralstonia mannitolilytica bacteraemia and gastroenteritis in a patient with rheumatoid arthritis: an emerging nosocomial infection.
Topics: Anti-Bacterial Agents; Arthritis, Rheumatoid; Bacteremia; Cefoperazone; Cross Infection; Diarrhea; Female; Gastroenteritis; Gram-Negative Bacterial Infections; Humans; Middle Aged; Ralstonia; Sulbactam | 2021 |
A case report of rash induced by cefoperazone sodium and sulbactam sodium plus metronidazole sodium chloride combined with morphine hydrochloride.
Topics: Adult; Anti-Bacterial Agents; Cefoperazone; Cesarean Section; Chlorides; Drug Therapy, Combination; Exanthema; Female; Humans; Metronidazole; Morphine Derivatives; Pregnancy; Sodium Chloride; Sulbactam | 2020 |
Deferasirox (ExJade): An FDA-Approved AIEgen Platform with Unique Photophysical Properties.
Topics: Alkaline Phosphatase; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Biomarkers; Cefoperazone; Deferasirox; Fluorescent Dyes; Light; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microscopy, Confocal; Microscopy, Fluorescence; Pseudomonas aeruginosa; Sulbactam | 2021 |
Bloodstream infections caused by ST2 Acinetobacter baumannii: risk factors, antibiotic regimens, and virulence over 6 years period in China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Respiration, Artificial; Retrospective Studies; Risk Factors; Sepsis; Sulbactam; Thrombocytopenia; Tigecycline; Virulence; Young Adult | 2021 |
Successful treatment of a patient with multi-site infection of cerebrospinal fluid and testis due to Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Cefoperazone; Cerebrospinal Fluid; Drug Combinations; Epididymis; Humans; Klebsiella Infections; Klebsiella pneumoniae; Magnetic Resonance Imaging; Male; Meropenem; Middle Aged; Perineum; Skull; Sulbactam; Testis; Ultrasonography; Vancomycin | 2021 |
Comparison of antibiotic-associated diarrhea caused by cefoperazone/sulbactam or piperacillin/tazobactam in neurosurgery patients.
Topics: Anti-Bacterial Agents; Cefoperazone; Diarrhea; Humans; Microbial Sensitivity Tests; Neurosurgery; Penicillanic Acid; Piperacillin; Retrospective Studies; Sulbactam; Tazobactam | 2021 |
P1-6: Clinical effectiveness of cefoperazone-sulbactam versus piperacillin-tazobactam for the treatment of pneumonia in the elderly population.
Topics: Aged; Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pneumonia; Sulbactam; Treatment Outcome | 2021 |
Clinical effectiveness of cefoperazone-sulbactam vs. piperacillin-tazobactam for the treatment of pneumonia in elderly patients.
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; Cohort Studies; Community-Acquired Infections; Female; Frail Elderly; Healthcare-Associated Pneumonia; Humans; Male; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated; Retrospective Studies; Sulbactam; Treatment Outcome | 2022 |
Resistance pattern of infected chronic wound isolates and factors associated with bacterial resistance to third generation cephalosporins at Mbarara Regional Referral Hospital, Uganda.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefixime; Cefoperazone; Cefpodoxime; Ceftizoxime; Cephalosporins; Chronic Disease; Drug Resistance, Bacterial; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sulbactam; Uganda; Wound Infection | 2021 |
Observation of clinical efficacy of the cefoperazone/sulbactam anti-infective regimen in the treatment of multidrug-resistant Acinetobacter baumannii lung infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; Drug Resistance, Multiple, Bacterial; Female; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam; Tigecycline; Treatment Outcome | 2022 |
Investigation and Analysis of Infection among Inpatients in a Tertiary Hospital in Shanghai.
Topics: Adult; Anti-Bacterial Agents; Cefoperazone; China; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Humans; Inpatients; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Sulbactam; Tertiary Care Centers | 2022 |
Nitrite Promotes ROS Production to Potentiate Cefoperazone-Sulbactam-Mediated Elimination to Lab-Evolved and Clinical-Evolved Pseudomonas aeruginosa.
Topics: Acetylcysteine; Anti-Bacterial Agents; Cefoperazone; Furaldehyde; Humans; Hydrogen Peroxide; NAD; Nitrites; Oxidoreductases; Pseudomonas aeruginosa; Pyruvates; Reactive Oxygen Species; Sulbactam | 2022 |
In vitro activity of eravacycline and cefoperazone/ sulbactam against extensively-drug resistant and pan-drug resistant Acinetobacter baumannii isolates from a tertiary hospital in Greece.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cefoperazone; Drug Resistance, Multiple, Bacterial; Greece; Humans; Microbial Sensitivity Tests; Sulbactam; Tertiary Care Centers; Tetracyclines | 2022 |
Pharmacovigilance of cutaneous adverse drug reactions in associations with drugs and medical conditions: a retrospective study of hospitalized patients.
Topics: Cefoperazone; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Pharmacovigilance; Retrospective Studies; Sulbactam | 2022 |
The Investigation on Nosocomial Infection of Acinetobacter baumannii and the Clinical Analysis of Sequential Therapy of Cefoperazone/Sulbactam Sodium for Intracranial Infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Case-Control Studies; Cefoperazone; Cross Infection; Humans; Retrospective Studies; Sodium; Sulbactam; Tigecycline | 2022 |
Differential Proteomic and Genomic Comparison of Resistance Mechanism of Pseudomonas aeruginosa to Cefoperazone Sodium/Sulbactam Sodium.
Topics: Anti-Bacterial Agents; Cefoperazone; China; Humans; Microbial Sensitivity Tests; Proteomics; Pseudomonas aeruginosa; Retrospective Studies; Sodium; Sulbactam | 2022 |
Antibiotic Sensitivity of
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Proteus Infections; Proteus mirabilis; Sulbactam; Sulfamethoxazole; Urinary Calculi; Urinary Tract Infections | 2022 |
Characteristics of and antibiotic resistance in urinary tract pathogens isolated from patients with upper urinary tract stones.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefoperazone; Drug Resistance, Bacterial; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Male; Microbial Sensitivity Tests; Piperacillin; Sulbactam; Tazobactam; Urinary Calculi; Urinary Tract; Urinary Tract Infections | 2023 |
Cross-reactivity between piperacillin-tazobactam and cefoperazone-sulbactam in drug-induced immune thrombocytopenia.
Topics: Aged; Anti-Bacterial Agents; Cefoperazone; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Purpura, Thrombocytopenic, Idiopathic; Sulbactam | 2023 |
Effect of Cefoperazone/Sulbactam on Blood Coagulation Function in Infected Emergency Department Patients and the Necessity of Vitamin K1 (VK1) Preventive Intervention: A Single-Center, Retrospective Analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Blood Coagulation; Blood Coagulation Disorders; Cefoperazone; Emergency Service, Hospital; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam; Vitamin K 1 | 2023 |
Clinical Treatment Options for Carbapenem-Resistant Gram-Negative Infections in China: a Single Center Real-World Experience.
Topics: Carbapenems; Cefoperazone; China; Humans; Retrospective Studies; Sulbactam | 2023 |
The clinical efficacy of cefoperazone-sulbactam versus piperacillin-tazobactam in the treatment of severe community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Cefoperazone; Community-Acquired Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; Sulbactam; Treatment Outcome | 2023 |
Case report: A rare multidrug-resistant
Topics: Anti-Bacterial Agents; Cefoperazone; Escherichia coli; Humans; Infant; Infant, Newborn; Meningoencephalitis; Sulbactam | 2023 |
Development and validation of a nomogram for predicting cefoperazone/sulbactam-induced hypoprothrombinaemia in Hospitalized adult patients.
Topics: Adult; Cefoperazone; Humans; Hypoprothrombinemias; Nomograms; Retrospective Studies; Sulbactam | 2023 |
Safety of Tigecycline in Patients on Antithrombotic Therapy: A Single-Center Retrospective Study.
Topics: Afibrinogenemia; Anti-Bacterial Agents; Cefoperazone; Fibrinogen; Fibrinolytic Agents; Hemoglobins; Hemorrhage; Humans; Retrospective Studies; Sulbactam; Tigecycline | 2023 |